<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33302607</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2642</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9122642</ELocationID><Abstract><AbstractText>Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) are heterogeneous, progressive diseases with frequently overlapping symptoms characterized by a loss of neurons. Studies have suggested relations between neurodegenerative diseases for many years (e.g., regarding the aggregation of toxic proteins or triggering endogenous cell death pathways). We gathered publicly available genomic, transcriptomic, and proteomic data from 177 studies and more than one million patients to detect shared genetic patterns between the neurodegenerative diseases on three analyzed omics-layers. The results show a remarkably high number of shared differentially expressed genes between the transcriptomic and proteomic levels for all conditions, while showing a significant relation between genomic and proteomic data between AD and PD and AD and ALS. We identified a set of 139 genes being differentially expressed in several transcriptomic experiments of all four diseases. These 139 genes showed overrepresented gene ontology (GO) Terms involved in the development of neurodegeneration, such as response to heat and hypoxia, positive regulation of cytokines and angiogenesis, and RNA catabolic process. Furthermore, the four analyzed neurodegenerative diseases (NDDs) were clustered by their mean direction of regulation throughout all transcriptomic studies for this set of 139 genes, with the closest relation regarding this common gene set seen between AD and HD. GO-Term and pathway analysis of the proteomic overlap led to biological processes (BPs), related to protein folding and humoral immune response. Taken together, we could confirm the existence of many relations between Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis on transcriptomic and proteomic levels by analyzing the pathways and GO-Terms arising in these intersections. The significance of the connection and the striking relation of the results to processes leading to neurodegeneration between the transcriptomic and proteomic data for all four analyzed neurodegenerative diseases showed that exploring many studies simultaneously, including multiple omics-layers of different neurodegenerative diseases simultaneously, holds new relevant insights that do not emerge from analyzing these data separately. Furthermore, the results shed light on processes like the humoral immune response that have previously been described only for certain diseases. Our data therefore suggest human patients with neurodegenerative diseases should be addressed as complex biological systems by integrating multiple underlying data sources.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruffini</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3342-6756</Identifier><AffiliationInfo><Affiliation>Institute for Human Genetics, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leibniz Institute for Resilience Research, Leibniz Association, Wallstra&#xdf;e 7, 55122 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klingenberg</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Human Genetics, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schweiger</LastName><ForeName>Susann</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Human Genetics, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerber</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Human Genetics, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063990" MajorTopicYN="N">Gene Ontology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056724" MajorTopicYN="N">Immunity, Humoral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Huntington&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">multi-omics</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>11</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33302607</ArticleId><ArticleId IdType="pmc">PMC7764447</ArticleId><ArticleId IdType="doi">10.3390/cells9122642</ArticleId><ArticleId IdType="pii">cells9122642</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Serrano-Pozo A., Frosch M.P., Masliah E., Hyman B.T. Neuropathological Alterations in Alzheimer Disease. Cold Spring Harb. Perspect. Med. 2011;1:a006189. doi: 10.1101/cshperspect.a006189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006189</ArticleId><ArticleId IdType="pmc">PMC3234452</ArticleId><ArticleId IdType="pubmed">22229116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nat. Cell Biol. 2006;443:780&#x2013;786. doi: 10.1038/nature05291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05291</ArticleId><ArticleId IdType="pubmed">17051204</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteves A.R., Cardoso S.M. Differential protein expression in diverse brain areas of Parkinson&#x2019;s and Alzheimer&#x2019;s disease patients. Sci. Rep. 2020;10:1&#x2013;22. doi: 10.1038/s41598-020-70174-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-70174-z</ArticleId><ArticleId IdType="pmc">PMC7403590</ArticleId><ArticleId IdType="pubmed">32753661</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain R., Zubair H., Pursell S., Shahab M. Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches. Brain Sci. 2018;8:177. doi: 10.3390/brainsci8090177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci8090177</ArticleId><ArticleId IdType="pmc">PMC6162719</ArticleId><ArticleId IdType="pubmed">30223579</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie T., Deng L., Mei P., Zhou Y., Wang B., Zhang J., Lin J., Wei Y., Zhang X., Xu R. A genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations. Neurobiol. Aging. 2014;35:1778.e9&#x2013;1778.e23. doi: 10.1016/j.neurobiolaging.2014.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.014</ArticleId><ArticleId IdType="pubmed">24529757</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger B.N., Dickson D.W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 2017;9:a028035. doi: 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028035</ArticleId><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L., Cookson M.R., Petrucelli L., La Spada A.R. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat. Neurosci. 2018;21:1300&#x2013;1309. doi: 10.1038/s41593-018-0237-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0237-7</ArticleId><ArticleId IdType="pmc">PMC6278826</ArticleId><ArticleId IdType="pubmed">30258237</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz F.I., Geschwind D.H. Molecular Genetics of Neurodegenerative Dementias. Cold Spring Harb. Perspect. Biol. 2016;9:a023705. doi: 10.1101/cshperspect.a023705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a023705</ArticleId><ArticleId IdType="pmc">PMC5378052</ArticleId><ArticleId IdType="pubmed">27940516</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C., Grenier-Boley B., Lambert J.-C. Genetics of Alzheimer&#x2019;s disease: Where we are, and where we are going. Curr. Opin. Neurobiol. 2020;61:40&#x2013;48. doi: 10.1016/j.conb.2019.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2019.11.024</ArticleId><ArticleId IdType="pubmed">31863938</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed X., Bandr&#xe9;s-Ciga S., Blauwendraat C., Cookson M.R. The role of monogenic genes in idiopathic Parkinson&#x2019;s disease. Neurobiol. Dis. 2019;124:230&#x2013;239. doi: 10.1016/j.nbd.2018.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.11.012</ArticleId><ArticleId IdType="pmc">PMC6363864</ArticleId><ArticleId IdType="pubmed">30448284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalingam S., Levy L.M. Genetics of Huntington Disease. Am. J. Neuroradiol. 2013;35:1070&#x2013;1072. doi: 10.3174/ajnr.A3772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A3772</ArticleId><ArticleId IdType="pubmed">24231851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Brown R.H. Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb. Perspect. Med. 2018;8:a024125. doi: 10.1101/cshperspect.a024125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sys S.J., Fournier D., Horenko I., Endres K., Gerber S. Dynamics of Associations Between Single Nucleotide Polymorphisms in Relation to Alzheimer&#x2019;s Disease Captured with a New Measure of Linkage Disequilibrium. Genom. Comput. Biol. 2018;4:e100045. doi: 10.18547/gcb.2018.vol4.iss2.e100045.</Citation><ArticleIdList><ArticleId IdType="doi">10.18547/gcb.2018.vol4.iss2.e100045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewel C., Kaiser J., Wierczeiko A., Linke J., Reinhardt C., Endres K., Gerber S. Common miRNA Patterns of Alzheimer&#x2019;s Disease and Parkinson&#x2019;s Disease and Their Putative Impact on Commensal Gut Microbiota. Front. Neurosci. 2019;13:113. doi: 10.3389/fnins.2019.00113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00113</ArticleId><ArticleId IdType="pmc">PMC6411762</ArticleId><ArticleId IdType="pubmed">30890906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanan V.K., Saykin A.J. Pathways to neurodegeneration: Mechanistic insights from GWAS in Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and related disorders. Am. J. Neurodegener. Dis. 2013;2:145&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3783830</ArticleId><ArticleId IdType="pubmed">24093081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredesen D.E., Rao R.V., Mehlen P. Cell death in the nervous system. Nat. Cell Biol. 2006;443:796&#x2013;802. doi: 10.1038/nature05293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05293</ArticleId><ArticleId IdType="pmc">PMC3970704</ArticleId><ArticleId IdType="pubmed">17051206</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo F., Liu X., Cai H., Le W. Autophagy in neurodegenerative diseases: Pathogenesis and therapy. Brain Pathol. 2017;28:3&#x2013;13. doi: 10.1111/bpa.12545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12545</ArticleId><ArticleId IdType="pmc">PMC5739982</ArticleId><ArticleId IdType="pubmed">28703923</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva D.F., Esteves A.R., Oliveira C.R., Cardoso S.M. Mitochondrial Metabolism Power SIRT2-Dependent Deficient Traffic Causing Alzheimer&#x2019;s-Disease Related Pathology. Mol. Neurobiol. 2017;54:4021&#x2013;4040. doi: 10.1007/s12035-016-9951-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9951-x</ArticleId><ArticleId IdType="pubmed">27311773</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteves A.R., Ardu&#xed;no D.M., Silva D.F., Viana S.D., Pereira F.C., Cardoso S.M. Mitochondrial Metabolism Regulates Microtubule Acetylome and Autophagy Trough Sirtuin-2: Impact for Parkinson&#x2019;s Disease. Mol. Neurobiol. 2017;55:1440&#x2013;1462. doi: 10.1007/s12035-017-0420-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0420-y</ArticleId><ArticleId IdType="pubmed">28168426</ArticleId></ArticleIdList></Reference><Reference><Citation>Briston T., Hicks A.R. Mitochondrial dysfunction and neurodegenerative proteinopathies: Mechanisms and prospects for therapeutic intervention. Biochem. Soc. Trans. 2018;46:829&#x2013;842. doi: 10.1042/BST20180025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20180025</ArticleId><ArticleId IdType="pmc">PMC6103456</ArticleId><ArticleId IdType="pubmed">29986938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010;345:91&#x2013;104. doi: 10.1007/s11010-010-0563-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-010-0563-x</ArticleId><ArticleId IdType="pubmed">20730621</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Miranda F., Hetz C. Current Topics in Microbiology and Immunology. Volume 414. Springer Science and Business Media LLC; Cham, Switzerland: 2017. ER Stress and Neurodegenerative Disease: A Cause or Effect Relationship? pp. 131&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">28864830</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns N.J., Lee V.M.-Y., Trojanowski J.Q. The cytoskeleton in neurodegenerative diseases. J. Pathol. 2004;204:438&#x2013;449. doi: 10.1002/path.1650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1650</ArticleId><ArticleId IdType="pmc">PMC3011821</ArticleId><ArticleId IdType="pubmed">15495240</ArticleId></ArticleIdList></Reference><Reference><Citation>Eira J., Silva C.S., Sousa M.M., Liz M.A. The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders. Prog. Neurobiol. 2016;141:61&#x2013;82. doi: 10.1016/j.pneurobio.2016.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.04.007</ArticleId><ArticleId IdType="pubmed">27095262</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith D.M. Could a Common Mechanism of Protein Degradation Impairment Underlie Many Neurodegenerative Diseases? J. Exp. Neurosci. 2018;12:12. doi: 10.1177/1179069518794675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179069518794675</ArticleId><ArticleId IdType="pmc">PMC6102758</ArticleId><ArticleId IdType="pubmed">30147359</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaudeau T.A., Anderson R.T., Smith D.M. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers. Nat. Commun. 2018;9:1&#x2013;14. doi: 10.1038/s41467-018-03509-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03509-0</ArticleId><ArticleId IdType="pmc">PMC5854577</ArticleId><ArticleId IdType="pubmed">29545515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wielgat P., Braszko J.J. Significance of the cell adhesion molecules and sialic acid in neurodegeneration. Adv. Med. Sci. 2012;57:23&#x2013;30. doi: 10.2478/v10039-012-0011-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/v10039-012-0011-0</ArticleId><ArticleId IdType="pubmed">22440941</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M., Michalopoulou M., Nikolaou C., Cambouri C., Rombos A., Dimitrakopoulos A., Vassilopoulos D. The role of soluble intercellular adhesion molecules in neurodegenerative disorders. J. Neurol. Sci. 2005;228:129&#x2013;135. doi: 10.1016/j.jns.2004.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2004.11.001</ArticleId><ArticleId IdType="pubmed">15694193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman M.A. Interactions between cell adhesion and the synaptic vesicle cycle in Parkinson&#x2019;s disease. Med. Hypotheses. 2014;83:203&#x2013;207. doi: 10.1016/j.mehy.2014.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2014.04.029</ArticleId><ArticleId IdType="pubmed">24837686</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Kummer M.P., Latz E. Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol. 2014;14:463&#x2013;477. doi: 10.1038/nri3705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3705</ArticleId><ArticleId IdType="pubmed">24962261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Seo J.H., Suh Y.H. &#x3b1;-Synuclein, Parkinson&#x2019;s disease, and Alzheimer&#x2019;s disease. Parkinsonism Relat Disord. 2004;10:S9&#x2013;S13. doi: 10.1016/j.parkreldis.2003.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2003.11.005</ArticleId><ArticleId IdType="pubmed">15109581</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckmann B.L., Tummers B., Green D.R. Crashing the computer: Apoptosis vs. necroptosis in neuroinflammation. Cell Death Differ. 2018;26:41&#x2013;52. doi: 10.1038/s41418-018-0195-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0195-3</ArticleId><ArticleId IdType="pmc">PMC6294765</ArticleId><ArticleId IdType="pubmed">30341422</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty K.R., Guillot-Sestier M.-V., Town T. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive? Brain Res. 2015;1617:155&#x2013;173. doi: 10.1016/j.brainres.2014.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.09.008</ArticleId><ArticleId IdType="pmc">PMC4362937</ArticleId><ArticleId IdType="pubmed">25218556</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamim A., Mahmood T., Ahsan F., Kumar A., Bagga P. Lipids: An insight into the neurodegenerative disorders. Clin. Nutr. Exp. 2018;20:1&#x2013;19. doi: 10.1016/j.yclnex.2018.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yclnex.2018.05.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-A., Lemire M., Choufani S., Butcher D.T., Grafodatskaya D., Zanke B.W., Gallinger S., Hudson T.J., Weksberg R. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8:203&#x2013;209. doi: 10.4161/epi.23470.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/epi.23470</ArticleId><ArticleId IdType="pmc">PMC3592906</ArticleId><ArticleId IdType="pubmed">23314698</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson E.C.B., Dammer E.B., Duong D.M., Ping L., Zhou M., Yin L., Higginbotham L.A., Guajardo A., White B., Troncoso J.C., et al. Large-scale proteomic analysis of Alzheimer&#x2019;s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med. 2020;26:769&#x2013;780. doi: 10.1038/s41591-020-0815-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0815-6</ArticleId><ArticleId IdType="pmc">PMC7405761</ArticleId><ArticleId IdType="pubmed">32284590</ArticleId></ArticleIdList></Reference><Reference><Citation>Joe E., Ringman J.M. Cognitive symptoms of Alzheimer&#x2019;s disease: Clinical management and prevention. BMJ. 2019;367:l6217. doi: 10.1136/bmj.l6217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l6217</ArticleId><ArticleId IdType="pubmed">31810978</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P., Blennow K., Breteler M.M.B., de Strooper B., Frisoni G.B., Salloway S., Van der Flier W.M. Alzheimer&#x2019;s disease. Lancet. 2016;388:505&#x2013;517. doi: 10.1016/S0140-6736(15)01124-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)01124-1</ArticleId><ArticleId IdType="pubmed">26921134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. Alzheimer&#x2019;s disease. Lancet. 2011;377:1019&#x2013;1031. doi: 10.1016/S0140-6736(10)61349-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61349-9</ArticleId><ArticleId IdType="pubmed">21371747</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239&#x2013;259. doi: 10.1007/BF00308809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308809</ArticleId><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandelkow E. Tau in Alzheimer&#x2019;s disease. Trends Cell Biol. 1998;8:425&#x2013;427. doi: 10.1016/S0962-8924(98)01368-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(98)01368-3</ArticleId><ArticleId IdType="pubmed">9854307</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal K., Grundke-Iqbal I. Neurofibrillary pathology leads to synaptic loss and not the other way around in Alzheimer disease. J. Alzheimer&#x2019;s Dis. 2002;4:235&#x2013;238. doi: 10.3233/JAD-2002-4313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2002-4313</ArticleId><ArticleId IdType="pubmed">12226542</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilherme M.D.S., Todorov H., Osterhof C., M&#xf6;llerke A., Cub K., Hankeln T., Gerber S., Endres K. Impact of Acute and Chronic Amyloid-&#x3b2; Peptide Exposure on Gut Microbial Commensals in the Mouse. Front. Microbiol. 2020;11:1008. doi: 10.3389/fmicb.2020.01008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01008</ArticleId><ArticleId IdType="pmc">PMC7251927</ArticleId><ArticleId IdType="pubmed">32508799</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauer W., Przedborski S. Parkinson&#x2019;s disease: Mechanisms and models. Neuron. 2003;39:889&#x2013;909. doi: 10.1016/S0896-6273(03)00568-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00568-3</ArticleId><ArticleId IdType="pubmed">12971891</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis A.W., Evanoff B.A., Lian M., Criswell S.R., Racette B.A. Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries. Neuroepidemiology. 2010;34:143&#x2013;151. doi: 10.1159/000275491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000275491</ArticleId><ArticleId IdType="pmc">PMC2865395</ArticleId><ArticleId IdType="pubmed">20090375</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovic J. Parkinson&#x2019;s disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry. 2008;79:368&#x2013;376. doi: 10.1136/jnnp.2007.131045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.131045</ArticleId><ArticleId IdType="pubmed">18344392</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge A. Biology of Parkinson&#x2019;s disease: Pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialog- Clin. Neurosci. 2004;6:259&#x2013;280. doi: 10.31887/dcns.2004.6.3/galexander.</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/dcns.2004.6.3/galexander</ArticleId><ArticleId IdType="pmc">PMC3181806</ArticleId><ArticleId IdType="pubmed">22033559</ArticleId></ArticleIdList></Reference><Reference><Citation>Berardelli A., Rothwell J.C., Thompson P.D., Hallett M. Pathophysiology of bradykinesia in Parkinson&#x2019;s disease. Brain. 2001;124:2131&#x2013;2146. doi: 10.1093/brain/124.11.2131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/124.11.2131</ArticleId><ArticleId IdType="pubmed">11673316</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano M., Galvan L., D&#xe9;glon N., Brouillet E. Mitochondria in Huntington&#x2019;s disease. Biochim. Et Biophys. Acta (Bba)-Mol. Basis Dis. 2010;1802:52&#x2013;61. doi: 10.1016/j.bbadis.2009.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.07.012</ArticleId><ArticleId IdType="pubmed">19682570</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuade L.R., Balachandran A., Scott H.A., Khaira S., Baker M.S., Schmidt U. Proteomics of Huntington&#x2019;s Disease-Affected Human Embryonic Stem Cells Reveals an Evolving Pathology Involving Mitochondrial Dysfunction and Metabolic Disturbances. J. Proteome Res. 2014;13:5648&#x2013;5659. doi: 10.1021/pr500649m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr500649m</ArticleId><ArticleId IdType="pubmed">25316320</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross C.A., Tabrizi S.J. Huntington&#x2019;s disease: From molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10:83&#x2013;98. doi: 10.1016/S1474-4422(10)70245-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70245-3</ArticleId><ArticleId IdType="pubmed">21163446</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt J. Behavioral Changes in Huntington Disease. Cogn. Behav. Neurol. 2018;31:26&#x2013;35. doi: 10.1097/WNN.0000000000000147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNN.0000000000000147</ArticleId><ArticleId IdType="pmc">PMC6005379</ArticleId><ArticleId IdType="pubmed">29561317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Hong Y., Li X.-J., Li S. Subcellular Clearance and Accumulation of Huntington Disease Protein: A Mini-Review. Front. Mol. Neurosci. 2016;9:27. doi: 10.3389/fnmol.2016.00027.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00027</ArticleId><ArticleId IdType="pmc">PMC4838617</ArticleId><ArticleId IdType="pubmed">27147961</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker F.O. Huntington&#x2019;s disease. Lancet. 2007;369:218&#x2013;228. doi: 10.1016/S0140-6736(07)60111-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60111-1</ArticleId><ArticleId IdType="pubmed">17240289</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos R.A.C. Huntington&#x2019;s disease: A clinical review. Orphanet J. Rare Dis. 2010;5:40. doi: 10.1186/1750-1172-5-40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-5-40</ArticleId><ArticleId IdType="pmc">PMC3022767</ArticleId><ArticleId IdType="pubmed">21171977</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson C.D., Davidson B.L. Huntington&#x2019;s disease: Progress toward effective disease-modifying treatments and a cure. Hum. Mol. Genet. 2010;19:R98&#x2013;R102. doi: 10.1093/hmg/ddq148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq148</ArticleId><ArticleId IdType="pmc">PMC2875055</ArticleId><ArticleId IdType="pubmed">20421366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J., Borasio G. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031&#x2013;2041. doi: 10.1016/S0140-6736(07)60944-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60944-1</ArticleId><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.L., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2008;4:3&#x2013;22. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 2013;16:571&#x2013;579. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J. Glial cells in amyotrophic lateral sclerosis. Exp. Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Novellino F., Sacc&#xe0; V., Donato A., Zaffino P., Spadea M.F., Vismara M.F.M., Arcidiacono B., Malara N., Presta I., Donato G. Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases. Int. J. Mol. Sci. 2020;21:1115. doi: 10.3390/ijms21031115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031115</ArticleId><ArticleId IdType="pmc">PMC7036760</ArticleId><ArticleId IdType="pubmed">32046139</ArticleId></ArticleIdList></Reference><Reference><Citation>E Renton A., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Groen E.J.N., Koppers M., Berg L.H.V.D., Pasterkamp R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Nie Y., Yu J. An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases. PLoS ONE. 2015;10:e0143045. doi: 10.1371/journal.pone.0143045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0143045</ArticleId><ArticleId IdType="pmc">PMC4648499</ArticleId><ArticleId IdType="pubmed">26575483</ArticleId></ArticleIdList></Reference><Reference><Citation>Arneson D., Zhang Y., Yang X., Narayanan M. Shared mechanisms among neurodegenerative diseases: From genetic factors to gene networks. J. Genet. 2018;97:795&#x2013;806. doi: 10.1007/s12041-018-0963-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12041-018-0963-3</ArticleId><ArticleId IdType="pmc">PMC6211183</ArticleId><ArticleId IdType="pubmed">30027910</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazarian A., Yashin A.I., Kulminski A.M. Genome-wide analysis of genetic predisposition to Alzheimer&#x2019;s disease and related sex disparities. Alzheimer&#x2019;s Res. Ther. 2019;11:1&#x2013;21. doi: 10.1186/s13195-018-0458-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-018-0458-8</ArticleId><ArticleId IdType="pmc">PMC6330399</ArticleId><ArticleId IdType="pubmed">30636644</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards T.L., Scott W.K., Almonte C., Burt A., Powell E.H., Beecham G.W., Wang L., Z&#xfc;chner S., Konidari I., Wang G., et al. Genome-Wide Association Study Confirms SNPs inSNCAand theMAPTRegion as Common Risk Factors for Parkinson Disease. Ann. Hum. Genet. 2010;74:97&#x2013;109. doi: 10.1111/j.1469-1809.2009.00560.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-1809.2009.00560.x</ArticleId><ArticleId IdType="pmc">PMC2853717</ArticleId><ArticleId IdType="pubmed">20070850</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherva R., Tripodis Y., Bennett D.A., Chibnik L.B., Crane P.K., De Jager P.L., Farrer L.A., Saykin A.J., Shulman J.M., Naj A., et al. Genome-wide association study of the rate of cognitive decline in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2014;10:45&#x2013;52. doi: 10.1016/j.jalz.2013.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2013.01.008</ArticleId><ArticleId IdType="pmc">PMC3760995</ArticleId><ArticleId IdType="pubmed">23535033</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Van Vught P.W., Blauw H.M., Franke L., Saris C.G., Andersen P., Bosch L.V.D., De Jong S., Van&#x2019;t Slot R., Birve A., et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: A genome-wide association study. Lancet Neurol. 2007;6:869&#x2013;877. doi: 10.1016/S1474-4422(07)70222-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70222-3</ArticleId><ArticleId IdType="pubmed">17827064</ArticleId></ArticleIdList></Reference><Reference><Citation>Laaksovirta H., Peuralinna T., Schymick J.C., Scholz S.W., Lai S.-L., Myllykangas L., Sulkava R., Jansson L., Hernandez D.G., Gibbs J.R., et al. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: A genome-wide association study. Lancet Neurol. 2010;9:978&#x2013;985. doi: 10.1016/S1474-4422(10)70184-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70184-8</ArticleId><ArticleId IdType="pmc">PMC2965392</ArticleId><ArticleId IdType="pubmed">20801718</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwee L.C., Liu Y., Haynes C., Gibson J.R., Stone A., Schichman S.A., Kamel F., Nelson L.M., Topol B., Van Den Eeden S.K., et al. A High-Density Genome-Wide Association Screen of Sporadic ALS in US Veterans. PLoS ONE. 2012;7:e32768. doi: 10.1371/journal.pone.0032768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032768</ArticleId><ArticleId IdType="pmc">PMC3314660</ArticleId><ArticleId IdType="pubmed">22470424</ArticleId></ArticleIdList></Reference><Reference><Citation>A Van Es M., Van Vught P.W., Blauw H.M., Franke L., Saris C.G., Bosch L.V.D., De Jong S.W., De Jong V., Baas F., Slot R.V., et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2008;40:29&#x2013;31. doi: 10.1038/ng.2007.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2007.52</ArticleId><ArticleId IdType="pubmed">18084291</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L., Tian Y., Chen Y., Wei Q., Chen F., Cao B., Wu Y., Zhao B., Chen X., Xie C., et al. Identification of TYW3/CRYZ and FGD4 as susceptibility genes for amyotrophic lateral sclerosis. Neurol. Genet. 2019;5:e375. doi: 10.1212/NXG.0000000000000375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000375</ArticleId><ArticleId IdType="pmc">PMC6878836</ArticleId><ArticleId IdType="pubmed">31872054</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekker A.M., Diekstra F.P., Pulit S.L., Tazelaar G.H.P., Van Der Spek R.A., Van Rheenen W., Van Eijk K.R., Calvo A., Brunetti M., Van Damme P., et al. Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis. Sci. Rep. 2019;9:5931. doi: 10.1038/s41598-019-42091-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42091-3</ArticleId><ArticleId IdType="pmc">PMC6459905</ArticleId><ArticleId IdType="pubmed">30976013</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A., Mok K., Newhouse S., E Weale M., Smith B.N., Vance C., Johnson L., Veldink J.H., Van Es M.A., Van Den Berg L.H., et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: A genome-wide association study. Lancet Neurol. 2010;9:986&#x2013;994. doi: 10.1016/S1474-4422(10)70197-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70197-6</ArticleId><ArticleId IdType="pmc">PMC3257853</ArticleId><ArticleId IdType="pubmed">20801717</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Veldink J.H., Saris C.G.J., Blauw H.M., Van Vught P.W.J., Birve A., Lemmens R., Schelhaas H.J., Groen E.J.N., Huisman M.H.B., et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 2009;41:1083&#x2013;1087. doi: 10.1038/ng.442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.442</ArticleId><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>The ALSGEN Consortium Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34. Neurobiol. Aging. 2012;34:357.e7&#x2013;357.e19. doi: 10.1016/j.neurobiolaging.2012.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.07.017</ArticleId><ArticleId IdType="pmc">PMC3839234</ArticleId><ArticleId IdType="pubmed">22959728</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng M., Wei L., Zuo X., Tian Y., Xie F., Hu P., Zhu C., Yu F., Meng Y., Wang H., et al. Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis. Nat. Genet. 2013;45:697&#x2013;700. doi: 10.1038/ng.2627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2627</ArticleId><ArticleId IdType="pubmed">23624525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo M.-T., Kauppi K., Fan C.-C., Sanyal N., Reas E.T., Sundar V., Lee W.-C., Desikan R.S., McEvoy L.K., Chen C.-H. Identification of genetic heterogeneity of Alzheimer&#x2019;s disease across age. Neurobiol. Aging. 2019;84:243.e1&#x2013;243.e9. doi: 10.1016/j.neurobiolaging.2019.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.02.022</ArticleId><ArticleId IdType="pmc">PMC6783343</ArticleId><ArticleId IdType="pubmed">30979435</ArticleId></ArticleIdList></Reference><Reference><Citation>Goris A., Van Setten J., Diekstra F., Ripke S., Patsopoulos N.A., Sawcer S.J., International Multiple Sclerosis Genetics Consortium. Van Es M., Australia and New Zealand MS Genetics Consortium. Andersen P.M., et al. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;23:1916&#x2013;1922. doi: 10.1093/hmg/ddt574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt574</ArticleId><ArticleId IdType="pmc">PMC3943520</ArticleId><ArticleId IdType="pubmed">24234648</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra F.P., Van Deerlin V.M., Van Swieten J.C., Al-Chalabi A., Ludolph A.C., Weishaupt J.H., Hardiman O., Landers J.E., Brown R.H., Van Es M.A., et al. C9orf72andUNC13Aare shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome-wide meta-analysis. Ann. Neurol. 2014;76:120&#x2013;133. doi: 10.1002/ana.24198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24198</ArticleId><ArticleId IdType="pmc">PMC4137231</ArticleId><ArticleId IdType="pubmed">24931836</ArticleId></ArticleIdList></Reference><Reference><Citation>Landers J.E., Melki J., Meininger V., Glass J.D., Van Den Berg L.H., Van Es M.A., Sapp P.C., Van Vught P.W.J., McKenna-Yasek D.M., Blauw H.M., et al. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2009;106:9004&#x2013;9009. doi: 10.1073/pnas.0812937106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812937106</ArticleId><ArticleId IdType="pmc">PMC2683883</ArticleId><ArticleId IdType="pubmed">19451621</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., Registry P., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., Van Der Spek R.A.A., V&#xf5;sa U., De Jong S., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle P., et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018;97:1268&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Latourelle J.C., Pankratz N., Dumitriu A., Wilk J.B., Goldwurm S., Pezzoli G., Mariani C.B., DeStefano A.L., Halter C., Gusella J.F., et al. Genomewide association study for onset age in Parkinson disease. Bmc Med Genet. 2009;10:98. doi: 10.1186/1471-2350-10-98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-10-98</ArticleId><ArticleId IdType="pmc">PMC2758866</ArticleId><ArticleId IdType="pubmed">19772629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Lin Y., Li X., Driver J.A., Liang L. Shared genetic architecture between metabolic traits and Alzheimer&#x2019;s disease: A large-scale genome-wide cross-trait analysis. Qual. Life Res. 2019;138:271&#x2013;285. doi: 10.1007/s00439-019-01988-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-019-01988-9</ArticleId><ArticleId IdType="pmc">PMC7193309</ArticleId><ArticleId IdType="pubmed">30805717</ArticleId></ArticleIdList></Reference><Reference><Citation>Feulner T.M., Laws S.M., Friedrich P., Wagenpfeil S., Wurst S.H.R., Riehle C., A Kuhn K., Krawczak M., Schreiber S., Nikolaus S., et al. Examination of the current top candidate genes for AD in a genome-wide association study. Mol. Psychiatry. 2009;15:756&#x2013;766. doi: 10.1038/mp.2008.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2008.141</ArticleId><ArticleId IdType="pubmed">19125160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer P.L., Xu H., Woltjer R.L., Westaway S.K., Clark D., Erten-Lyons D., Kaye J., Welsh-Bohmer K.A., Troncoso J.C., Markesbery W.R., et al. Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study. Neurobiol. Aging. 2011;32:2113&#x2013;2122. doi: 10.1016/j.neurobiolaging.2010.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.01.010</ArticleId><ArticleId IdType="pmc">PMC2990809</ArticleId><ArticleId IdType="pubmed">20452100</ArticleId></ArticleIdList></Reference><Reference><Citation>Meda S.A., Narayanan B., Liu J., Perrone-Bizzozero N.I., Stevens M.C., Calhoun V.D., Glahn D.C., Shen L., Risacher S.L., Saykin A.J., et al. A large scale multivariate parallel ICA method reveals novel imaging&#x2013;genetic relationships for Alzheimer&#x2019;s disease in the ADNI cohort. NeuroImage. 2012;60:1608&#x2013;1621. doi: 10.1016/j.neuroimage.2011.12.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2011.12.076</ArticleId><ArticleId IdType="pmc">PMC3312985</ArticleId><ArticleId IdType="pubmed">22245343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamboh M.I., The Alzheimer&#x2019;s Disease Neuroimaging Initiative. Barmada M.M., Demirci F.Y., Minster R.L., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Saykin A.J., Sweet R.A., et al. Genome-wide association analysis of age-at-onset in Alzheimer&#x2019;s disease. Mol. Psychiatry. 2012;17:1340&#x2013;1346. doi: 10.1038/mp.2011.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2011.135</ArticleId><ArticleId IdType="pmc">PMC3262952</ArticleId><ArticleId IdType="pubmed">22005931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J., Wang X., Maruyama T., Ma Y., Zhang X., Mez J., Sherva R., Takeyama H., Lunetta K.L., Farrer L.A., et al. Genome-wide association study of Alzheimer&#x2019;s disease endophenotypes at prediagnosis stages. Alzheimer&#x2019;s Dement. 2018;14:623&#x2013;633. doi: 10.1016/j.jalz.2017.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.11.006</ArticleId><ArticleId IdType="pmc">PMC5938137</ArticleId><ArticleId IdType="pubmed">29274321</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold C., Hooli B.V., Mullin K., Liu T., Roehr J.T., Mattheisen M., Parrado A.R., Bertram L., Lange C., Tanzi R.E. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer&#x2019;s disease with OSBPL6, PTPRG, and PDCL. Mol. Psychiatry. 2016;21:1608&#x2013;1612. doi: 10.1038/mp.2015.218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.218</ArticleId><ArticleId IdType="pmc">PMC4970971</ArticleId><ArticleId IdType="pubmed">26830138</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings A.C., Jiang L., Edwards D.R.V., McCauley J.L., Laux R., McFarland L.L., Fuzzell D., Knebusch C., Caywood L., Reinhart-Mercer L., et al. Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene. Ann. Hum. Genet. 2012;76:342&#x2013;351. doi: 10.1111/j.1469-1809.2012.00721.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-1809.2012.00721.x</ArticleId><ArticleId IdType="pmc">PMC3419486</ArticleId><ArticleId IdType="pubmed">22881374</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasquillo M.M., Zou F., Pankratz V.S., Wilcox S.L., Ma L., Walker L.P., Younkin S.G., Younkin C.S., Younkin L.H., Bisceglio G.D., et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer&#x2019;s disease. Nat. Genet. 2009;41:192&#x2013;198. doi: 10.1038/ng.305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.305</ArticleId><ArticleId IdType="pmc">PMC2873177</ArticleId><ArticleId IdType="pubmed">19136949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosto G., Fu H., Vardarajan B.N., Lee J.H., Cheng R., Reyes-Dumeyer D., Lantigua R., Medrano M., Jimenez-Velazquez I.Z., Elkind M.S.V., et al. F-box/LRR -repeat protein 7 is genetically associated with Alzheimer&#x2019;s disease. Ann. Clin. Transl. Neurol. 2015;2:810&#x2013;820. doi: 10.1002/acn3.223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.223</ArticleId><ArticleId IdType="pmc">PMC4554442</ArticleId><ArticleId IdType="pubmed">26339675</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Palma E., Bustos B.I., Villam&#xe1;n C.F., Alarc&#xf3;n M., Avila M.E., Ugarte G.D., Reyes A.E., Opazo C.M., De Ferrari G.V., The Alzheimer&#x2019;s Disease Neuroimaging Initiative et al. Overrepresentation of Glutamate Signaling in Alzheimer&#x2019;s Disease: Network-Based Pathway Enrichment Using Meta-Analysis of Genome-Wide Association Studies. PLoS ONE. 2014;9:e95413. doi: 10.1371/journal.pone.0095413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095413</ArticleId><ArticleId IdType="pmc">PMC3995778</ArticleId><ArticleId IdType="pubmed">24755620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Lopez O., Sweet R.A., Becker J.T., DeKosky S.T., Barmada M.M., Feingold E.C., Demirci F.Y., Kamboh M.I. Genetic Determinants of Survival in Patients with Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2015;45:651&#x2013;658. doi: 10.3233/JAD-142442.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-142442</ArticleId><ArticleId IdType="pmc">PMC4486643</ArticleId><ArticleId IdType="pubmed">25649651</ArticleId></ArticleIdList></Reference><Reference><Citation>Yashin A.I., Fang F., Kovtun M., Wu D., Duan M., Arbeev K., Akushevich I., Kulminski A., Culminskaya I., Zhbannikov I., et al. Hidden heterogeneity in Alzheimer&#x2019;s disease: Insights from genetic association studies and other analyses. Exp. Gerontol. 2018;107:148&#x2013;160. doi: 10.1016/j.exger.2017.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2017.10.020</ArticleId><ArticleId IdType="pmc">PMC5920782</ArticleId><ArticleId IdType="pubmed">29107063</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman E.M., Webster J.A., Myers A.J., Hardy J., Dunckley T., Zismann V.L., Joshipura K.D., Pearson J.V., Hu-Lince D., Huentelman M.J., et al. GAB2 Alleles Modify Alzheimer&#x2019;s Risk in APOE &#x3b5;4 Carriers. Neuron. 2007;54:713&#x2013;720. doi: 10.1016/j.neuron.2007.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.05.022</ArticleId><ArticleId IdType="pmc">PMC2587162</ArticleId><ArticleId IdType="pubmed">17553421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Swaminathan S., Shen L., Risacher S.L., Nho K., Foroud T., Shaw L.M., Trojanowski J.Q., Potkin S.G., Huentelman M.J., et al. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurol. 2010;76:69&#x2013;79. doi: 10.1212/WNL.0b013e318204a397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318204a397</ArticleId><ArticleId IdType="pmc">PMC3030225</ArticleId><ArticleId IdType="pubmed">21123754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamboh M.I., for the Alzheimer&#x2019;s Disease Neuroimaging Initiative. Demirci F.Y., Wang X., Minster R.L., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Saykin A.J., Jun G., et al. Genome-wide association study of Alzheimer&#x2019;s disease. Transl. Psychiatry. 2012;2:e117. doi: 10.1038/tp.2012.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2012.45</ArticleId><ArticleId IdType="pmc">PMC3365264</ArticleId><ArticleId IdType="pubmed">22832961</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein J.L., Hua X., Morra J.H., Lee S., Hibar D.P., Ho A.J., Leow A.D., Toga A.W., Sul J.H., Kang H.M., et al. Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer&#x2019;s disease. NeuroImage. 2010;51:542&#x2013;554. doi: 10.1016/j.neuroimage.2010.02.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2010.02.068</ArticleId><ArticleId IdType="pmc">PMC2856746</ArticleId><ArticleId IdType="pubmed">20197096</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinelli-Boneschi F., Giacalone G., Magnani G., Biella G., Coppi E., Santangelo R., Brambilla P., Esposito F., Lupoli S., Clerici F., et al. Pharmacogenomics in Alzheimer&#x2019;s disease: A genome-wide association study of response to cholinesterase inhibitors. Neurobiol. Aging. 2013;34:1711.e7&#x2013;1711.e13. doi: 10.1016/j.neurobiolaging.2012.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.12.008</ArticleId><ArticleId IdType="pubmed">23374588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertram L., Lange C., Mullin K., Parkinson M., Hsiao M., Hogan M.F., Schjeide B.M., Hooli B., DiVito J., Ionita I., et al. Genome-wide Association Analysis Reveals Putative Alzheimer&#x2019;s Disease Susceptibility Loci in Addition to APOE. Am. J. Hum. Genet. 2008;83:623&#x2013;632. doi: 10.1016/j.ajhg.2008.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.10.008</ArticleId><ArticleId IdType="pmc">PMC2668052</ArticleId><ArticleId IdType="pubmed">18976728</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham R., Moskvina V., Sims R., Hollingworth P., Morgan A., Georgieva L., Dowzell K., Cichon S., Hillmer A.M., O&#x2019;Donovan M.C., et al. A genome-wide association study for late-onset Alzheimer&#x2019;s disease using DNA pooling. Bmc Med Genom. 2008;1:44. doi: 10.1186/1755-8794-1-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-1-44</ArticleId><ArticleId IdType="pmc">PMC2570675</ArticleId><ArticleId IdType="pubmed">18823527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanan V.K., for the Alzheimer&#x2019;s Disease Neuroimaging Initiative. Risacher S.L., Nho K., Kim S., Swaminathan S., Shen L., Foroud T.M., Hakonarson H., Huentelman M.J., et al. APOE and BCHE as modulators of cerebral amyloid deposition: A florbetapir PET genome-wide association study. Mol. Psychiatry. 2014;19:351&#x2013;357. doi: 10.1038/mp.2013.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2013.19</ArticleId><ArticleId IdType="pmc">PMC3661739</ArticleId><ArticleId IdType="pubmed">23419831</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher-Moser J., Levey A.I., Lah J.J., et al. Variant of TREM2 Associated with the Risk of Alzheimer&#x2019;s Disease. New Engl. J. Med. 2013;368:107&#x2013;116. doi: 10.1056/NEJMoa1211103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211103</ArticleId><ArticleId IdType="pmc">PMC3677583</ArticleId><ArticleId IdType="pubmed">23150908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E., Giovanello K.S., Saykin A.J., Xie F., Kong D., Wang Y., Yang L., Ibrahim J.G., Doraiswamy P.M., Zhu H., et al. Single-nucleotide polymorphisms are associated with cognitive decline at Alzheimer&#x2019;s disease conversion within mild cognitive impairment patients. Alzheimer&#x2019;s Dement. Diagn. Assess. Dis. Monit. 2017;8:86&#x2013;95. doi: 10.1016/j.dadm.2017.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2017.04.004</ArticleId><ArticleId IdType="pmc">PMC5440281</ArticleId><ArticleId IdType="pubmed">28560309</ArticleId></ArticleIdList></Reference><Reference><Citation>Marioni R.E., Harris S.E., Zhang Q., McRae A.F., Hagenaars S.P., Hill W.D., Davies G., Ritchie C.W., Gale C.R., Starr J.M., et al. GWAS on family history of Alzheimer&#x2019;s disease. Transl. Psychiatry. 2018;8:1&#x2013;7. doi: 10.1038/s41398-018-0150-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-018-0150-6</ArticleId><ArticleId IdType="pmc">PMC5959890</ArticleId><ArticleId IdType="pubmed">29777097</ArticleId></ArticleIdList></Reference><Reference><Citation>Traylor M., Adib-Samii P., Harold D., Dichgans M., Williams J., Lewis C.M., Dm H.S.M., Fornage M., Holliday E.G., Sharma P., et al. Shared genetic contribution to ischemic stroke and Alzheimer&#x2019;s disease. Ann. Neurol. 2016;79:739&#x2013;747. doi: 10.1002/ana.24621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24621</ArticleId><ArticleId IdType="pmc">PMC4864940</ArticleId><ArticleId IdType="pubmed">26913989</ArticleId></ArticleIdList></Reference><Reference><Citation>Furney S.J., Alzheimer&#x2019;s Disease Neuroimaging on behalf of the Alzheimer&#x2019;s Disease Neuroimaging Initiative and the AddNeuroMed Consortium. Simmons A.N., Breen G., Pedroso I., Lunnon K., Proitsi P., Hodges A., Powell J., Wahlund L.-O., et al. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer&#x2019;s disease. Mol. Psychiatry. 2011;16:1130&#x2013;1138. doi: 10.1038/mp.2010.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2010.123</ArticleId><ArticleId IdType="pmc">PMC5980656</ArticleId><ArticleId IdType="pubmed">21116278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A., Ohara T., Takahashi A., Aoki M., Fuyuno Y., Ashikawa K., Morihara T., Takeda M., Kamino K., Oshima E., et al. A genome-wide association study of late-onset Alzheimer&#x2019;s disease in a Japanese population. Psychiatr. Genet. 2015;25:139&#x2013;146. doi: 10.1097/YPG.0000000000000090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YPG.0000000000000090</ArticleId><ArticleId IdType="pubmed">26049409</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijsman E.M., Pankratz N.D., Choi Y., Rothstein J.H., Faber K.M., Cheng R., Lee J.H., Bird T.D., Bennett D.A., Diaz-Arrastia R., et al. Genome-Wide Association of Familial Late-Onset Alzheimer&#x2019;s Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE. Plos Genet. 2011;7:e1001308. doi: 10.1371/journal.pgen.1001308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1001308</ArticleId><ArticleId IdType="pmc">PMC3040659</ArticleId><ArticleId IdType="pubmed">21379329</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauwe J.S.K., Bailey M.H., Ridge P.G., Perry R., Wadsworth M.E., Hoyt K.L., Staley L.A., Karch C.M., Harari O., Cruchaga C., et al. Genome-Wide Association Study of CSF Levels of 59 Alzheimer&#x2019;s Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation. Plos Genet. 2014;10:e1004758. doi: 10.1371/journal.pgen.1004758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004758</ArticleId><ArticleId IdType="pmc">PMC4207667</ArticleId><ArticleId IdType="pubmed">25340798</ArticleId></ArticleIdList></Reference><Reference><Citation>Deming Y., Xia J., Cai Y., Lord J., Holmans P., Bertelsen S., Holtzman D., Morris J.C., Bales K., Pickering E.H., et al. A potential endophenotype for Alzheimer&#x2019;s disease: Cerebrospinal fluid clusterin. Neurobiol. Aging. 2015;37:208.e1&#x2013;208.e9. doi: 10.1016/j.neurobiolaging.2015.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.09.009</ArticleId><ArticleId IdType="pmc">PMC5118651</ArticleId><ArticleId IdType="pubmed">26545630</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster J.A., Myers A.J., Pearson J.V., Craig D.W., Hu-Lince D., Coon K.D., Zismann V.L., Beach T., Leung D.G., Bryden L., et al. Sorl1 as an Alzheimer&#x2019;s Disease Predisposition Gene? Neurodegener. Dis. 2007;5:60&#x2013;64. doi: 10.1159/000110789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000110789</ArticleId><ArticleId IdType="pubmed">17975299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S., EPAD Study Group. Mez J., Trittschuh E.H., Saykin A.J., Gibbons L.E., Fardo D.W., Wessels M., Bauman J., Moore M., et al. Genetic data and cognitively defined late-onset Alzheimer&#x2019;s disease subgroups. Mol. Psychiatry. 2020;25:2942&#x2013;2951. doi: 10.1038/s41380-018-0298-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-018-0298-8</ArticleId><ArticleId IdType="pmc">PMC6548676</ArticleId><ArticleId IdType="pubmed">30514930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ant&#xfa;nez C., Boada M., Gonz&#xe1;lez-P&#xe9;rez A., Gay&#xe1;n J., Ramirez-Lorca R., Marin J., Hernandez I., Moreno-Rey C., Mor&#xf3;n F.J., L&#xf3;pez-Arrieta J., et al. The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer&#x2019;s disease. Genome Med. 2011;3:33. doi: 10.1186/gm249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gm249</ArticleId><ArticleId IdType="pmc">PMC3219074</ArticleId><ArticleId IdType="pubmed">21627779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert J.-C., the European Alzheimer&#x2019;s Disease Initiative Investigators. Heath S., Even G., Campion D., Sleegers K., O Hiltunen M., Combarros O., Zelenika D., Bullido M.J., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer&#x2019;s disease. Nat. Genet. 2009;41:1094&#x2013;1099. doi: 10.1038/ng.439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.439</ArticleId><ArticleId IdType="pubmed">19734903</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Wetten S., Li L., Jean P.L.S., Upmanyu R., Surh L., Hosford D., Barnes M.R., Briley J.D., Borrie M., et al. Candidate Single-Nucleotide Polymorphisms From a Genomewide Association Study of Alzheimer Disease. Arch. Neurol. 2008;65:45&#x2013;53. doi: 10.1001/archneurol.2007.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2007.3</ArticleId><ArticleId IdType="pubmed">17998437</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyashita A., Koike A., Jun G.R., Wang L.-S., Takahashi S., Matsubara E., Kawarabayashi T., Shoji M., Tomita N., Arai H., et al. SORL1 Is Genetically Associated with Late-Onset Alzheimer&#x2019;s Disease in Japanese, Koreans and Caucasians. PLoS ONE. 2013;8:e58618. doi: 10.1371/annotation/fcb56ea7-d32a-4e45-818d-39cef330c731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/fcb56ea7-d32a-4e45-818d-39cef330c731</ArticleId><ArticleId IdType="pmc">PMC3614978</ArticleId><ArticleId IdType="pubmed">23565137</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C., Kauwe J.S., Harari O., Jin S.C., Cai Y., Karch C.M., Benitez B.A., Jeng A.T., Skorupa T., Carrell D., et al. GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer&#x2019;s Disease. Neuron. 2013;78:256&#x2013;268. doi: 10.1016/j.neuron.2013.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.026</ArticleId><ArticleId IdType="pmc">PMC3664945</ArticleId><ArticleId IdType="pubmed">23562540</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitz C., Jun G., Naj A., Rajbhandary R., Vardarajan B.N., Wang L.-S., Valladares O., Lin C.-F., Larson E.B., Graff-Radford N.R., et al. Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E &#x3f5;4, and the Risk of Late-Onset Alzheimer Disease in African Americans. JAMA. 2013;309:1483&#x2013;1492. doi: 10.1001/jama.2013.2973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.2973</ArticleId><ArticleId IdType="pmc">PMC3667653</ArticleId><ArticleId IdType="pubmed">23571587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth P., the GERAD Consortium. Sweet R.A., Sims R., Harold D., Russo G., Abraham R.T., Stretton A., Jones N., Gerrish A., et al. Genome-wide association study of Alzheimer&#x2019;s disease with psychotic symptoms. Mol. Psychiatry. 2012;17:1316&#x2013;1327. doi: 10.1038/mp.2011.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2011.125</ArticleId><ArticleId IdType="pmc">PMC3272435</ArticleId><ArticleId IdType="pubmed">22005930</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., et al. Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease. JAMA. 2010;303:1832&#x2013;1840. doi: 10.1001/jama.2010.574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.574</ArticleId><ArticleId IdType="pmc">PMC2989531</ArticleId><ArticleId IdType="pubmed">20460622</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusareva E.S., Twizere J.-C., Sleegers K., Dourlen P., Abisambra J.F., Meier S., Cloyd R., Weiss B., Dermaut B., Bessonov K., et al. Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer&#x2019;s disease. Neurobiol. Aging. 2018;72:188.e3&#x2013;188.e12. doi: 10.1016/j.neurobiolaging.2018.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.08.001</ArticleId><ArticleId IdType="pmc">PMC6769421</ArticleId><ArticleId IdType="pubmed">30201328</ArticleId></ArticleIdList></Reference><Reference><Citation>Coon K.D., Myers A.J., Craig D.W., Webster J.A., Pearson J.V., Lince D.H., Zismann V.L., Beach T.G., Leung D., Bryden L., et al. A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer&#x2019;s Disease. J. Clin. Psychiatry. 2007;68:613&#x2013;618. doi: 10.4088/JCP.v68n0419.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.v68n0419</ArticleId><ArticleId IdType="pubmed">17474819</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P.T., Alzheimer&#x2019; Disease Genetic Consortium. Estus S., Abner E.L., Parikh I., Malik M., Neltner J.H., Ighodaro E., Wang W.-X., Wilfred B.R., et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol. 2014;127:825&#x2013;843. doi: 10.1007/s00401-014-1282-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1282-2</ArticleId><ArticleId IdType="pmc">PMC4113197</ArticleId><ArticleId IdType="pubmed">24770881</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen I.E., Savage J.E., Watanabe K., Bryois J., Williams D.M., Steinberg S., Sealock J., Karlsson I.K., Hagg S., Athanasiu L., et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat. Genet. 2019;51:404&#x2013;413. doi: 10.1038/s41588-018-0311-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0311-9</ArticleId><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Grau S., De Rojas I., Hern&#xe1;ndez I., Quintela I., Montrreal L., Alegret M., Hern&#xe1;ndez-Olasagarre B., Madrid L., Gonz&#xe1;lez-Perez A., Maro&#xf1;as O., et al. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer&#x2019;s disease and three causality networks: The GR@ACE project. Alzheimer&#x2019;s Dement. 2019;15:1333&#x2013;1347. doi: 10.1016/j.jalz.2019.06.4950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.06.4950</ArticleId><ArticleId IdType="pubmed">31473137</ArticleId></ArticleIdList></Reference><Reference><Citation>Schott J.M., Crutch S.J., Carrasquillo M.M., Uphill J., Shakespeare T.J., Ryan N.S., Yong K.X., Lehmann M., Ertekin-Taner N., Graff-Radford N.R., et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2016;12:862&#x2013;871. doi: 10.1016/j.jalz.2016.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.01.010</ArticleId><ArticleId IdType="pmc">PMC4982482</ArticleId><ArticleId IdType="pubmed">26993346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez A., Van Der Flier W.M., Herold C., Ramonet D., Heilmann-Heimbach S., Lewczuk P., Popp J., Lacour A., Drichel D., Louwersheimer E., et al. SUCLG2 identified as both a determinator of CSF A&#x3b2;1-42 levels and an attenuator of cognitive decline in Alzheimer&#x2019;s disease. Hum. Mol. Genet. 2014;23:6644&#x2013;6658. doi: 10.1093/hmg/ddu372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu372</ArticleId><ArticleId IdType="pmc">PMC4240204</ArticleId><ArticleId IdType="pubmed">25027320</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun G.R., Chung J., Mez J., Barber R., Beecham G.W., Bennett D.A., Buxbaum J.D., Byrd G.S., Carrasquillo M.M., Crane P.K., et al. Transethnic genome-wide scan identifies novel Alzheimer&#x2019;s disease loci. Alzheimer&#x2019;s Dement. 2017;13:727&#x2013;738. doi: 10.1016/j.jalz.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5496797</ArticleId><ArticleId IdType="pubmed">28183528</ArticleId></ArticleIdList></Reference><Reference><Citation>Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer&#x2019;s disease. Nat. Genet. 2009;41:1088&#x2013;1093. doi: 10.1038/ng.440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.440</ArticleId><ArticleId IdType="pmc">PMC2845877</ArticleId><ArticleId IdType="pubmed">19734902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert J.-C., Grenier-Boley B., Harold D., Zelenika D., Chouraki V., Kamatani Y., Sleegers K., A Ikram M., Hiltunen M., Reitz C., et al. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer&#x2019;s disease. Mol. Psychiatry. 2013;18:461&#x2013;470. doi: 10.1038/mp.2012.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2012.14</ArticleId><ArticleId IdType="pmc">PMC3606943</ArticleId><ArticleId IdType="pubmed">22430674</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun G., IGAP Consortium. Ibrahim-Verbaas C.A., Vronskaya M., Lambert J.-C., Chung J., Naj A.C., Kunkle B.W., Wang L.-S., Bisceglio G., et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol. Psychiatry. 2016;21:108&#x2013;117. doi: 10.1038/mp.2015.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.23</ArticleId><ArticleId IdType="pmc">PMC4573764</ArticleId><ArticleId IdType="pubmed">25778476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.-C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer&#x2019;s disease. Nat. Genet. 2011;43:429&#x2013;435. doi: 10.1038/ng.803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.803</ArticleId><ArticleId IdType="pmc">PMC3084173</ArticleId><ArticleId IdType="pubmed">21460840</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinzen E.L., Need A.C., Hayden K.M., Chiba-Falek O., Roses A.D., Strittmatter W.J., Burke J.R., Hulette C.M., Welsh-Bohmer K.A., Goldstein D.B. Genome-Wide Scan of Copy Number Variation in Late-Onset Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2010;19:69&#x2013;77. doi: 10.3233/JAD-2010-1212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-1212</ArticleId><ArticleId IdType="pmc">PMC2883723</ArticleId><ArticleId IdType="pubmed">20061627</ArticleId></ArticleIdList></Reference><Reference><Citation>Naj A.C., Jun G., Beecham G.W., Wang L.-S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer&#x2019;s disease. Nat. Genet. 2011;43:436&#x2013;441. doi: 10.1038/ng.801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.801</ArticleId><ArticleId IdType="pmc">PMC3090745</ArticleId><ArticleId IdType="pubmed">21460841</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert J.-C., European Alzheimer&#x2019;s Disease Initiative (EADI) Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., Jun G., DeStefano A.L., Bis J.C., et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#x2019;s disease. Nat. Genet. 2013;45:1452&#x2013;1458. doi: 10.1038/ng.2802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2802</ArticleId><ArticleId IdType="pmc">PMC3896259</ArticleId><ArticleId IdType="pubmed">24162737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S.J., Armasu S.M., Biernacka J.M., Anderson K.J., Lesnick T.G., Rider D.N., Cunningham J.M., Ahlskog J.E., Frigerio R., Maraganore D.M. Genomic determinants of motor and cognitive outcomes in Parkinson&#x2019;s disease. Park. Relat. Disord. 2012;18:881&#x2013;886. doi: 10.1016/j.parkreldis.2012.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2012.04.025</ArticleId><ArticleId IdType="pmc">PMC3606821</ArticleId><ArticleId IdType="pubmed">22658654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallen Z.D., Chen H., Hill-Burns E.M., Factor S.A., Zabetian C.P., Payami H. Plasticity-related gene 3 (LPPR1) and age at diagnosis of Parkinson disease. Neurol. Genet. 2018;4:e271. doi: 10.1212/NXG.0000000000000271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000271</ArticleId><ArticleId IdType="pmc">PMC6186025</ArticleId><ArticleId IdType="pubmed">30338293</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Deng L., Zhang J., Fang X., Mei P., Cao X., Lin J., Wei Y., Zhang X., Xu R. A Pooling Genome-Wide Association Study Combining a Pathway Analysis for Typical Sporadic Parkinson&#x2019;s Disease in the Han Population of Chinese Mainland. Mol. Neurobiol. 2016;53:4302&#x2013;4318. doi: 10.1007/s12035-015-9331-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9331-y</ArticleId><ArticleId IdType="pubmed">26227905</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickrell J.K., Berisa T., Liu J.Z., S&#xe9;gurel L., Tung J.Y., A Hinds D. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 2016;48:709&#x2013;717. doi: 10.1038/ng.3570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3570</ArticleId><ArticleId IdType="pmc">PMC5207801</ArticleId><ArticleId IdType="pubmed">27182965</ArticleId></ArticleIdList></Reference><Reference><Citation>A Nalls M., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.-M., Saad M.H.F., Simonsanchez J., Schulte C., Lesage S., Sveinbjornsdottir S., et al. Imputation of sequence variants for identification of genetic risks for Parkinson&#x2019;s disease: A meta-analysis of genome-wide association studies. Lancet. 2011;377:641&#x2013;649. doi: 10.1016/s0140-6736(10)62345-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(10)62345-8</ArticleId><ArticleId IdType="pmc">PMC3696507</ArticleId><ArticleId IdType="pubmed">21292315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D.M., Doheny K.F., Paschall J., Pugh E., et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson&#x2019;s disease. Nat. Genet. 2010;42:781&#x2013;785. doi: 10.1038/ng.642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.642</ArticleId><ArticleId IdType="pmc">PMC2930111</ArticleId><ArticleId IdType="pubmed">20711177</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraganore D.M., De Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., Pant P.V.K., Frazer K.A., Cox D.R., Ballinger D.G. High-Resolution Whole-Genome Association Study of Parkinson Disease. Am. J. Hum. Genet. 2005;77:685&#x2013;693. doi: 10.1086/496902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/496902</ArticleId><ArticleId IdType="pmc">PMC1271381</ArticleId><ArticleId IdType="pubmed">16252231</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung H.-C., Scholz S., Matarin M., Sim&#xf3;n-S&#xe1;nchez J., Hernandez D., Britton A., Gibbs J.R., Langefeld C., Stiegert M.L., Schymick J., et al. Genome-wide genotyping in Parkinson&#x2019;s disease and neurologically normal controls: First stage analysis and public release of data. Lancet Neurol. 2006;5:911&#x2013;916. doi: 10.1016/S1474-4422(06)70578-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(06)70578-6</ArticleId><ArticleId IdType="pubmed">17052657</ArticleId></ArticleIdList></Reference><Reference><Citation>Naj A.C., Beecham G.W., Martin E.R., Gallins P.J., Powell E.H., Konidari I., Whitehead P.L., Cai G., Haroutunian V., Scott W.K., et al. Dementia Revealed: Novel Chromosome 6 Locus for Late-Onset Alzheimer Disease Provides Genetic Evidence for Folate-Pathway Abnormalities. Plos Genet. 2010;6:e1001130. doi: 10.1371/journal.pgen.1001130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1001130</ArticleId><ArticleId IdType="pmc">PMC2944795</ArticleId><ArticleId IdType="pubmed">20885792</ArticleId></ArticleIdList></Reference><Reference><Citation>Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson&#x2019;s disease. Nat. Genet. 2009;41:1303&#x2013;1307. doi: 10.1038/ng.485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.485</ArticleId><ArticleId IdType="pubmed">19915576</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankratz N., Wilk J.B., Latourelle J.C., DeStefano A.L., Halter C., Pugh E.W., Doheny K.F., Gusella J.F., Nichols W.C., Foroud T., et al. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Qual. Life Res. 2009;124:593&#x2013;605. doi: 10.1007/s00439-008-0582-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-008-0582-9</ArticleId><ArticleId IdType="pmc">PMC2627511</ArticleId><ArticleId IdType="pubmed">18985386</ArticleId></ArticleIdList></Reference><Reference><Citation>Do C.B., Tung J.Y., Dorfman E., Kiefer A.K., Drabant E.M., Francke U., Mountain J.L., Goldman S.M., Tanner C.M., Langston J.W., et al. Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson&#x2019;s Disease. PLoS Genet. 2011;7:e1002141. doi: 10.1371/journal.pgen.1002141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002141</ArticleId><ArticleId IdType="pmc">PMC3121750</ArticleId><ArticleId IdType="pubmed">21738487</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Cheng R., Verbitsky M., Kisselev S., Browne A., Mejia-Sanatana H., Louis E.D., Cote L.J., Andrews H.F., Waters C.H., et al. Genome-Wide association study identifies candidate genes for Parkinson&#x2019;s disease in an Ashkenazi Jewish population. Bmc Med Genet. 2011;12:104. doi: 10.1186/1471-2350-12-104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-12-104</ArticleId><ArticleId IdType="pmc">PMC3166909</ArticleId><ArticleId IdType="pubmed">21812969</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill-Burns E.M., Wissemann W.T., Hamza T.H., Factor S.A., Zabetian C.P., Payami H. Identification of a novel Parkinson&#x2019;s disease locus via stratified genome-wide association study. Bmc Genom. 2014;15:118. doi: 10.1186/1471-2164-15-118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-15-118</ArticleId><ArticleId IdType="pmc">PMC3925254</ArticleId><ArticleId IdType="pubmed">24511991</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis M.F., Cummings A.C., D&#x2019;Aoust L.N., Jiang L., Edwards D.R.V., Laux R., Reinhart-Mercer L., Fuzzell D., Scott W.K., Pericak-Vance M.A., et al. Parkinson disease loci in the mid-western Amish. Qual. Life Res. 2013;132:1213&#x2013;1221. doi: 10.1007/s00439-013-1316-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-013-1316-1</ArticleId><ArticleId IdType="pmc">PMC3797866</ArticleId><ArticleId IdType="pubmed">23793441</ArticleId></ArticleIdList></Reference><Reference><Citation>Biernacka J.M., Chung S.J., Armasu S.M., Anderson K.S., Lill C.M., Bertram L., Ahlskog J., Brighina L., Frigerio R., Maraganore D.M. Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson&#x2019;s disease. Park. Relat. Disord. 2016;32:25&#x2013;30. doi: 10.1016/j.parkreldis.2016.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2016.08.002</ArticleId><ArticleId IdType="pmc">PMC5125780</ArticleId><ArticleId IdType="pubmed">27545685</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang D., Nalls M.A., Hallgr&#xed;msd&#xf3;ttir I.B., Hunkapiller J., Van Der Brug M., Cai F., Kerchner G.A., Ayalon G., Bingol B., Sheng M., et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson&#x2019;s disease risk loci. Nat. Genet. 2017;49:1511&#x2013;1516. doi: 10.1038/ng.3955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3955</ArticleId><ArticleId IdType="pmc">PMC5812477</ArticleId><ArticleId IdType="pubmed">28892059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill-Burns E.M., Ross O.A., Wissemann W.T., Soto-Ortolaza A.I., Zareparsi S., Siuda J., Lynch T., Wszolek Z.K., Silburn P.A., Mellick G.D., et al. Identification of genetic modifiers of age-at-onset for familial Parkinson&#x2019;s disease. Hum. Mol. Genet. 2016;25:3849&#x2013;3862. doi: 10.1093/hmg/ddw206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw206</ArticleId><ArticleId IdType="pmc">PMC5216611</ArticleId><ArticleId IdType="pubmed">27402877</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad M., Lesage S., Saint-Pierre A., Corvol J.-C., Zelenika D., Lambert J.-C., Vidailhet M., Mellick G.D., Lohmann E., Durif F., et al. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson&#x2019;s disease in the European population. Hum. Mol. Genet. 2010;20:615&#x2013;627. doi: 10.1093/hmg/ddq497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq497</ArticleId><ArticleId IdType="pubmed">21084426</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue M.W., Schu M., Vardarajan B.N., Buros J., Green R.C., Go R.C.P., Griffith P., Obisesan T.O., Shatz R., Borenstein A., et al. A Comprehensive Genetic Association Study of Alzheimer Disease in African Americans. Arch. Neurol. 2011;68:1569&#x2013;1579. doi: 10.1001/archneurol.2011.646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.646</ArticleId><ArticleId IdType="pmc">PMC3356921</ArticleId><ArticleId IdType="pubmed">22159054</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankratz N., Beecham G.W., DeStefano A.L., Dawson T.M., Doheny K.F., Do S.A.F., Hamza T.H., Hung A.Y., Hyman B.T., Ivinson A.J., et al. Meta-analysis of Parkinson&#x2019;s Disease: Identification of a novel locus, RIT2. Ann. Neurol. 2012;71:370&#x2013;384. doi: 10.1002/ana.22687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22687</ArticleId><ArticleId IdType="pmc">PMC3354734</ArticleId><ArticleId IdType="pubmed">22451204</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacic V., Ozelius L.J., Clark L.N., Bar-Shira A., Gana-Weisz M., Gurevich T., Gusev A., Kedmi M., Kenny E.E., Liu X., et al. Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. Hum. Mol. Genet. 2014;23:4693&#x2013;4702. doi: 10.1093/hmg/ddu158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu158</ArticleId><ArticleId IdType="pmc">PMC4119402</ArticleId><ArticleId IdType="pubmed">24842889</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo J.N., Tan L.C., Irwan I.D., Au W.-L., Low H.Q., Prakash K.-M., Annuar A.A., Bei J., Chan A.Y., Chen C.-M., et al. Genome-wide association study of Parkinson&#x2019;s disease in East Asians. Hum. Mol. Genet. 2016;26:226&#x2013;232. doi: 10.1093/hmg/ddw379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw379</ArticleId><ArticleId IdType="pubmed">28011712</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecham G.W., Dickson D.W., Scott W.K., Martin E.R., Schellenberg G., Nuytemans K., Larson E.B., Buxbaum J., Trojanowski J.Q., Van Deerlin V.M., et al. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology. 2015;84:972&#x2013;980. doi: 10.1212/WNL.0000000000001332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001332</ArticleId><ArticleId IdType="pmc">PMC4352096</ArticleId><ArticleId IdType="pubmed">25663231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3;n-S&#xe1;nchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., et al. Genome-wide association study reveals genetic risk underlying Parkinson&#x2019;s disease. Nat. Genet. 2009;41:1308&#x2013;1312. doi: 10.1038/ng.487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.487</ArticleId><ArticleId IdType="pmc">PMC2787725</ArticleId><ArticleId IdType="pubmed">19915575</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls M.A., Blauwendraat C., Vallerga C.L., Heilbron K., Bandres-Ciga S., Chang D., Tan M.X., A Kia D., Noyce A.J., Xue A., et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: A meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091&#x2013;1102. doi: 10.1016/S1474-4422(19)30320-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30320-5</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauwendraat C., Reed X., Krohn L., Heilbron K., Bandres-Ciga S., Tan M., Gibbs J.R., Hernandez D.G., Kumaran R., Langston R., et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson&#x2019;s disease and Lewy body dementia. Brain. 2020;143:234&#x2013;248. doi: 10.1093/brain/awz350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz350</ArticleId><ArticleId IdType="pmc">PMC6935749</ArticleId><ArticleId IdType="pubmed">31755958</ArticleId></ArticleIdList></Reference><Reference><Citation>The UK Parkinson&#x2019;s Disease Consortium and The Wellcome Trust Case Control Consortium, 2. Spencer C.C., Plagnol V., Strange A., Gardner M., Paisan-Ruiz C., Band G., Barker R.A., Bellenguez C., Bhatia K., et al. Dissection of the genetics of Parkinson&#x2019;s disease identifies an additional association 5&#x2032; of SNCA and multiple associated haplotypes at 17q21. Hum. Mol. Genet. 2010;20:345&#x2013;353. doi: 10.1093/hmg/ddq469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq469</ArticleId><ArticleId IdType="pmc">PMC3005904</ArticleId><ArticleId IdType="pubmed">21044948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lill C.M., Roehr J.T., McQueen M.B., Kavvoura F.K., Bagade S., Schjeide B.-M.M., Schjeide L.M., Meissner E., Zauft U., Allen N.C., et al. Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson&#x2019;s Disease Genetics: The PDGene Database. Plos Genet. 2012;8:e1002548. doi: 10.1371/journal.pgen.1002548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002548</ArticleId><ArticleId IdType="pmc">PMC3305333</ArticleId><ArticleId IdType="pubmed">22438815</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauwendraat C., Heilbron K., Msc C.L.V., Bandres-Ciga S., Von Coelln R., Pihlstr&#xf8;m L., Sim&#xf3;n-S&#xe1;nchez J., Schulte C., Sharma M., Msc L.K., et al. Parkinson&#x2019;s disease age at onset genome-wide association study: Defining heritability, genetic loci, and &#x3b1;-synuclein mechanisms. Mov. Disord. 2019;34:866&#x2013;875. doi: 10.1002/mds.27659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27659</ArticleId><ArticleId IdType="pmc">PMC6579628</ArticleId><ArticleId IdType="pubmed">30957308</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X., Pickering E., Liu Y.C., Hall S., Fournier H., Katz E., DeChairo B., John S., Van Eerdewegh P., Soares H., et al. Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer&#x2019;s Disease. PLoS ONE. 2011;6:e16616. doi: 10.1371/journal.pone.0016616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0016616</ArticleId><ArticleId IdType="pmc">PMC3044719</ArticleId><ArticleId IdType="pubmed">21390209</ArticleId></ArticleIdList></Reference><Reference><Citation>A Nalls M., Pankratz N., Lill C.M., Do C.B., Hernandez D.G., Saad M., DeStefano A.L., Kara E., Bras J., Sharma M., et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson&#x2019;s disease. Nat. Genet. 2014;46:989&#x2013;993. doi: 10.1038/ng.3043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3043</ArticleId><ArticleId IdType="pmc">PMC4146673</ArticleId><ArticleId IdType="pubmed">25064009</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciga S.B., Ahmed S., Sabir M.S., Blauwendraat C., Adarmes-G&#xf3;mez A.D., Msc I.B., Msc M.B., Msc D.B., Carrillo F., Msc M.C., et al. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight. Mov. Disord. 2019;34:1851&#x2013;1863. doi: 10.1002/mds.27864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27864</ArticleId><ArticleId IdType="pubmed">31660654</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Zhou X., Perkerson R.B., Baker M., Jenkins G.D., Serie D.J., Ghidoni R., Benussi L., Binetti G., De Munain A.L., et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: A genome-wide association study. Lancet Neurol. 2018;17:548&#x2013;558. doi: 10.1016/S1474-4422(18)30126-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30126-1</ArticleId><ArticleId IdType="pmc">PMC6237181</ArticleId><ArticleId IdType="pubmed">29724592</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao M.J., Kim K.-H., Shin J.W., Lucente D., Wheeler V.C., Li H., Roach J.C., Hood L., Wexler N.S., Jardim L.B., et al. Population-specific genetic modification of Huntington&#x2019;s disease in Venezuela. Plos Genet. 2018;14:e1007274. doi: 10.1371/journal.pgen.1007274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007274</ArticleId><ArticleId IdType="pmc">PMC5965898</ArticleId><ArticleId IdType="pubmed">29750799</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss D.J.H., Pardi&#xf1;as A.F., Langbehn D., Lo K., Leavitt B.R., Roos R.A., Durr A., Mead S., Holmans P., Jones L., et al. Identification of genetic variants associated with Huntington&#x2019;s disease progression: A genome-wide association study. Lancet Neurol. 2017;16:701&#x2013;711. doi: 10.1016/S1474-4422(17)30161-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30161-8</ArticleId><ArticleId IdType="pubmed">28642124</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin S., Tomik B., Bradley D.G., Slowik A., Hardiman O. Screening for replication of genome-wide SNP associations in sporadic ALS. Eur. J. Hum. Genet. 2008;17:213&#x2013;218. doi: 10.1038/ejhg.2008.194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2008.194</ArticleId><ArticleId IdType="pmc">PMC2986065</ArticleId><ArticleId IdType="pubmed">18987618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.-J., Chen C.-M., Pai T.-W., Chang H.-T., Hwang C.-S. A genome-wide association study on amyotrophic lateral sclerosis in the Taiwanese Han population. Biomark. Med. 2016;10:597&#x2013;611. doi: 10.2217/bmm.15.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm.15.115</ArticleId><ArticleId IdType="pubmed">26580837</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin R.L., Kenna K.P., Vajda A., Bede P., Elamin M., Cronin S., Donaghy C.G., Bradley D.G., Hardiman O. A second-generation Irish genome-wide association study for amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:1221.e7&#x2013;1221.e13. doi: 10.1016/j.neurobiolaging.2014.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.08.030</ArticleId><ArticleId IdType="pubmed">25442119</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymick J.C., Scholz S.W., Fung H.-C., Britton A., Arepalli S., Gibbs J.R., Lombardo F., Matarin M., Kasperaviciute D., Hernandez D.G., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: First stage analysis and public release of data. Lancet Neurol. 2007;6:322&#x2013;328. doi: 10.1016/S1474-4422(07)70037-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70037-6</ArticleId><ArticleId IdType="pubmed">17362836</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin S., Berger S., Ding J., Schymick J.C., Washecka N., Hernandez D.G., Greenway M.J., Bradley D.G., Traynor B.J., Hardiman O. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum. Mol. Genet. 2007;17:768&#x2013;774. doi: 10.1093/hmg/ddm361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm361</ArticleId><ArticleId IdType="pubmed">18057069</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T., Wilhite S.E., Ledoux P., Evangelista C., Kim I.F., Tomashevsky M., Marshall K.A., Phillippy K.H., Sherman P.M., Holko M., et al. NCBI GEO: Archive for functional genomics data sets&#x2014;Update. Nucleic Acids Res. 2013;41:D991&#x2013;D995. doi: 10.1093/nar/gks1193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1193</ArticleId><ArticleId IdType="pmc">PMC3531084</ArticleId><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>Papatheodorou I., Fonseca N.A., Keays M., Tang Y.A., Barrera E., Bazant W., Burke M., F&#xfc;llgrabe A., Fuentes A.M.-P., George N., et al. Expression Atlas: Gene and protein expression across multiple studies and organisms. Nucleic Acids Res. 2018;46:D246&#x2013;D251. doi: 10.1093/nar/gkx1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1158</ArticleId><ArticleId IdType="pmc">PMC5753389</ArticleId><ArticleId IdType="pubmed">29165655</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchtold N.C., Coleman P.D., Cribbs D.H., Rogers J., Gillen D.L., Cotman C.W. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer&#x2019;s disease. Neurobiol. Aging. 2013;34:1653&#x2013;1661. doi: 10.1016/j.neurobiolaging.2012.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.11.024</ArticleId><ArticleId IdType="pmc">PMC4022280</ArticleId><ArticleId IdType="pubmed">23273601</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama M., Oka S., Leon J., Ninomiya T., Honda H., Sasaki K., Iwaki T., Ohara T., Sasaki T., LaFerla F.M., et al. Altered Expression of Diabetes-Related Genes in Alzheimer&#x2019;s Disease Brains: The Hisayama Study. Cereb. Cortex. 2014;24:2476&#x2013;2488. doi: 10.1093/cercor/bht101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bht101</ArticleId><ArticleId IdType="pmc">PMC4128707</ArticleId><ArticleId IdType="pubmed">23595620</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopa E.G., Tanis K.Q., Miller M.C., Nikonova E.V., Podtelezhnikov A.A., Finney E.M., Stone D.J., Camargo L.M., Parker L., Verma A., et al. Comparative transcriptomics of choroid plexus in Alzheimer&#x2019;s disease, frontotemporal dementia and Huntington&#x2019;s disease: Implications for CSF homeostasis. Fluids Barriers Cns. 2018;15:1&#x2013;10. doi: 10.1186/s12987-018-0102-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-018-0102-9</ArticleId><ArticleId IdType="pmc">PMC5977762</ArticleId><ArticleId IdType="pubmed">29848382</ArticleId></ArticleIdList></Reference><Reference><Citation>Simunovic F., Yi M., Wang Y., Macey L., Brown L.T., Krichevsky A.M., Andersen S.L., Stephens R.M., Benes F.M., Sonntag K.-C. Gene expression profiling of substantia nigra dopamine neurons: Further insights into Parkinson&#x2019;s disease pathology. Brain. 2009;132:1795&#x2013;1809. doi: 10.1093/brain/awn323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn323</ArticleId><ArticleId IdType="pmc">PMC2724914</ArticleId><ArticleId IdType="pubmed">19052140</ArticleId></ArticleIdList></Reference><Reference><Citation>Elstner M., Morris C.M., Heim K., Bender A., Mehta D., Jaros E., Klopstock T., Meitinger T., Turnbull D.M., Prokisch H. Expression analysis of dopaminergic neurons in Parkinson&#x2019;s disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol. 2011;122:75&#x2013;86. doi: 10.1007/s00401-011-0828-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0828-9</ArticleId><ArticleId IdType="pubmed">21541762</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley B.E., Gardai S.J., Emig-Agius D., Bessarabova M., Ivliev A.E., Sch&#xfc;le B., Alexander J., Wallace W., Halliday G.M., Langston J.W., et al. Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson&#x2019;s Disease Reveals Underlying Causal Mechanisms. PLoS ONE. 2014;9:e102909. doi: 10.1371/journal.pone.0102909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102909</ArticleId><ArticleId IdType="pmc">PMC4149353</ArticleId><ArticleId IdType="pubmed">25170892</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijkstra A.A., Ingrassia A., De Menezes R.X., Van Kesteren R.E., Rozemuller A.J.M., Heutink P., Van De Berg W.D.J. Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson&#x2019;s Disease. PLoS ONE. 2015;10:e0128651. doi: 10.1371/journal.pone.0128651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128651</ArticleId><ArticleId IdType="pmc">PMC4472235</ArticleId><ArticleId IdType="pubmed">26087293</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumitriu A., Latourelle J.C., Hadzi T.C., Pankratz N., Garza D., Miller J.P., Vance J.M., Foroud T., Beach T.G., Myers R.H. Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate FOXO1 and Genes under Its Transcriptional Regulation. PLoS Genet. 2012;8:e1002794. doi: 10.1371/journal.pgen.1002794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002794</ArticleId><ArticleId IdType="pmc">PMC3386245</ArticleId><ArticleId IdType="pubmed">22761592</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumitriu A., Golji J., Labadorf A.T., Gao B., Beach T.G., Myers R.H., Longo K.A., Latourelle J.C. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease. Bmc Med Genom. 2015;9:1&#x2013;17. doi: 10.1186/s12920-016-0164-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-016-0164-y</ArticleId><ArticleId IdType="pmc">PMC4722694</ArticleId><ArticleId IdType="pubmed">26793951</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherzer C.R., Eklund A.C., Morse L.J., Liao Z., Locascio J.J., Fefer D., Schwarzschild M.A., Schlossmacher M.G., Hauser M.A., Vance J.M., et al. Molecular markers of early Parkinson&#x2019;s disease based on gene expression in blood. Proc. Natl. Acad. Sci. USA. 2007;104:955&#x2013;960. doi: 10.1073/pnas.0610204104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0610204104</ArticleId><ArticleId IdType="pmc">PMC1766335</ArticleId><ArticleId IdType="pubmed">17215369</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesnick T.G., Papapetropoulos S., Mash D.C., Ffrench-Mullen J., Shehadeh L., De Andrade M., Henley J.R., A Rocca W., Ahlskog J.E., Maraganore D.M. A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease. Plos Genet. 2007;3:e98. doi: 10.1371/journal.pgen.0030098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0030098</ArticleId><ArticleId IdType="pmc">PMC1904362</ArticleId><ArticleId IdType="pubmed">17571925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., James M., Middleton F.A., Davis R.L. Transcriptional analysis of multiple brain regions in Parkinson&#x2019;s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am. J. Med Genet. Part B Neuropsychiatr. Genet. 2005;137B:5&#x2013;16. doi: 10.1002/ajmg.b.30195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.30195</ArticleId><ArticleId IdType="pubmed">15965975</ArticleId></ArticleIdList></Reference><Reference><Citation>Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., Landfield P.W. Incipient Alzheimer&#x2019;s disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA. 2004;101:2173&#x2013;2178. doi: 10.1073/pnas.0308512100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0308512100</ArticleId><ArticleId IdType="pmc">PMC357071</ArticleId><ArticleId IdType="pubmed">14769913</ArticleId></ArticleIdList></Reference><Reference><Citation>Calligaris R., Banica M., Roncaglia P., Robotti E., Finaurini S., Vlachouli C., Antonutti L., Iorio F., Carissimo A., Cattaruzza T., et al. Blood transcriptomics of drug-na&#xef;ve sporadic Parkinson&#x2019;s disease patients. Bmc Genom. 2015;16:1&#x2013;14. doi: 10.1186/s12864-015-2058-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-015-2058-3</ArticleId><ArticleId IdType="pmc">PMC4625854</ArticleId><ArticleId IdType="pubmed">26510930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ring K.L., An M.C., Zhang N., O&#x2019;Brien R.N., Ramos E.M., Gao F., Atwood R., Bailus B.J., Melov S., Mooney S.D., et al. Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington&#x2019;s Disease Neural Stem Cells. Stem Cell Rep. 2015;5:1023&#x2013;1038. doi: 10.1016/j.stemcr.2015.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.11.005</ArticleId><ArticleId IdType="pmc">PMC4682390</ArticleId><ArticleId IdType="pubmed">26651603</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15a;wito&#x144;ska K., Szlachcic W.J., Handschuh L., Wojciechowski P., Marczak &#x141;., Stelmaszczuk M., Figlerowicz M., Figiel M. Identification of Altered Developmental Pathways in Human Juvenile HD iPSC With 71Q and 109Q Using Transcriptome Profiling. Front. Cell. Neurosci. 2019;12 doi: 10.3389/fncel.2018.00528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00528</ArticleId><ArticleId IdType="pmc">PMC6345698</ArticleId><ArticleId IdType="pubmed">30713489</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dalahmah O., Sosunov A.A., Shaik A., Ofori K., Liu Y., Vonsattel J.P., Adorjan I., Menon V., Goldman J.E. Single-nucleus RNA-seq identifies Huntington disease astrocyte states. Acta Neuropathol. Commun. 2020;8:1&#x2013;21. doi: 10.1186/s40478-020-0880-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-0880-6</ArticleId><ArticleId IdType="pmc">PMC7029580</ArticleId><ArticleId IdType="pubmed">32070434</ArticleId></ArticleIdList></Reference><Reference><Citation>Labadorf A., Hoss A.G., Lagomarsino V.N., Latourelle J.C., Hadzi T.C., Bregu J., Macdonald M.E., Gusella J.F., Chen J.-F., Akbarian S., et al. RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression. PLoS ONE. 2015;10:e0143563. doi: 10.1371/journal.pone.0143563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0143563</ArticleId><ArticleId IdType="pmc">PMC4670106</ArticleId><ArticleId IdType="pubmed">26636579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Park J.W., Ramachandran S., Zhang Y., Tseng Y.-T., Shen S., Waldvogel H.J., Curtis M.A., Faull R.L.M., Troncoso J.C., et al. Transcriptome sequencing reveals aberrant alternative splicing in Huntington&#x2019;s disease. Hum. Mol. Genet. 2016;25:3454&#x2013;3466. doi: 10.1093/hmg/ddw187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw187</ArticleId><ArticleId IdType="pmc">PMC5179942</ArticleId><ArticleId IdType="pubmed">27378699</ArticleId></ArticleIdList></Reference><Reference><Citation>Feyeux M., Bourgois-Rocha F., Redfern A., Giles P., Lefort N., Aubert S., Bonnefond C., Bugi A., Ruiz M., Deglon N., et al. Early transcriptional changes linked to naturally occurring Huntington&#x2019;s disease mutations in neural derivatives of human embryonic stem cells. Hum. Mol. Genet. 2012;21:3883&#x2013;3895. doi: 10.1093/hmg/dds216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds216</ArticleId><ArticleId IdType="pubmed">22678061</ArticleId></ArticleIdList></Reference><Reference><Citation>The HD iPSC Consortium Developmental alterations in Huntington&#x2019;s disease neural cells and pharmacological rescue in cells and mice. Nat. Neurosci. 2017;20:648&#x2013;660. doi: 10.1038/nn.4532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4532</ArticleId><ArticleId IdType="pmc">PMC5610046</ArticleId><ArticleId IdType="pubmed">28319609</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim R.G., Quan C., Reyes-Ortiz A.M., Lutz S.E., Kedaigle A.J., Gipson T.A., Wu J., Vatine G.D., Stocksdale J., Casale M.S., et al. Huntington&#x2019;s Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits. Cell Rep. 2017;19:1365&#x2013;1377. doi: 10.1016/j.celrep.2017.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.04.021</ArticleId><ArticleId IdType="pmc">PMC5646270</ArticleId><ArticleId IdType="pubmed">28514657</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S.R., Tom C.M., Wang Y., Bresee C., Rushton D., Mathkar P.P., Tang J., Mattis V.B. Human Huntington&#x2019;s Disease iPSC-Derived Cortical Neurons Display Altered Transcriptomics, Morphology, and Maturation. Cell Rep. 2018;25:1081&#x2013;1096.e6. doi: 10.1016/j.celrep.2018.09.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.09.076</ArticleId><ArticleId IdType="pubmed">30355486</ArticleId></ArticleIdList></Reference><Reference><Citation>Blalock E.M., Buechel H.M., Popovic J., Geddes J.W., Landfield P.W. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer&#x2019;s disease. J. Chem. Neuroanat. 2011;42:118&#x2013;126. doi: 10.1016/j.jchemneu.2011.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2011.06.007</ArticleId><ArticleId IdType="pmc">PMC3163806</ArticleId><ArticleId IdType="pubmed">21756998</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L.E., Ferraiuolo L., Goodall E.F., Heath P.R., Higginbottom A., Mortiboys H., Hollinger H.C., Hartley J.A., Brockington A., Burness C.E., et al. Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS) PLoS ONE. 2010;5:e9872. doi: 10.1371/journal.pone.0009872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009872</ArticleId><ArticleId IdType="pmc">PMC2844426</ArticleId><ArticleId IdType="pubmed">20352044</ArticleId></ArticleIdList></Reference><Reference><Citation>Otake K., Kamiguchi H., Hirozane Y. Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. Bmc Med. Genom. 2019;12:1&#x2013;11. doi: 10.1186/s12920-019-0473-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-019-0473-z</ArticleId><ArticleId IdType="pmc">PMC6329125</ArticleId><ArticleId IdType="pubmed">30630471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Zucca S., Pandini C., Diamanti L., Bordoni M., Sproviero D., Arigoni M., Olivero M., Pansarasa O., Ceroni M., et al. Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients. Sci. Rep. 2018;8:1&#x2013;11. doi: 10.1038/s41598-018-20679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId><ArticleId IdType="pmc">PMC5799454</ArticleId><ArticleId IdType="pubmed">29402919</ArticleId></ArticleIdList></Reference><Reference><Citation>Swindell W.R., Kruse C., List E.O., Berryman D.E., Kopchick J.J. ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia. J. Transl. Med. 2019;17:170. doi: 10.1186/s12967-019-1909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1909-0</ArticleId><ArticleId IdType="pmc">PMC6530130</ArticleId><ArticleId IdType="pubmed">31118040</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Belzil V.V., Batra R., Ross C.A., Gendron T.F., Pregent L.J., Murray M.E., Overstreet K.K., Piazza-Johnston A.E., Desaro P., et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015;18:1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R., Allen S.P., Goodall E.F., Kramer S., Ponger L.-L., Heath P.R., Milo M., Hollinger H.C., Walsh T., Highley J.R., et al. Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol. Appl. Neurobiol. 2015;41:201&#x2013;226. doi: 10.1111/nan.12147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12147</ArticleId><ArticleId IdType="pmc">PMC4329387</ArticleId><ArticleId IdType="pubmed">24750211</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Pratt G.A., Vu A.Q., Hutt K.R., Martinez F.J., Sundararaman B., Batra R., Freese P.D., Lambert N.J., Huelga S.C., et al. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun. 2016;7:12143. doi: 10.1038/ncomms12143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12143</ArticleId><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O., Montal V., Sirisi S.S., L&#xf3;pez-Pernas G., Cervera-Carles L., Querol-Vilaseca M., Munoz L., Belbin O., Alcolea D., Molina-Porcel L., et al. Characterization of the motor cortex transcriptome supports microgial-related key events in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2020;7:e829. doi: 10.1212/NXI.0000000000000829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000829</ArticleId><ArticleId IdType="pmc">PMC7371375</ArticleId><ArticleId IdType="pubmed">32669313</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginbotham L., Ping L., Dammer E.B., Duong D.M., Zhou M., Gearing M., Hurst C., Glass J.D., Factor S.A., Johnson E.C.B., et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer&#x2019;s disease. Sci. Adv. 2020;6:eaaz9360. doi: 10.1126/sciadv.aaz9360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz9360</ArticleId><ArticleId IdType="pmc">PMC7577712</ArticleId><ArticleId IdType="pubmed">33087358</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W.S., Dunckley T., Beach T.G., Grover A., Mastroeni D., Walker D.G., Caselli R.J., Kukull W.A., McKeel D., Morris J.C., et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol. Genom. 2007;28:311&#x2013;322. doi: 10.1152/physiolgenomics.00208.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00208.2006</ArticleId><ArticleId IdType="pmc">PMC2259385</ArticleId><ArticleId IdType="pubmed">17077275</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistri M., Velmeshev D., Makhmutova M., Faghihi M.A. Transcriptomics Profiling of Alzheimer&#x2019;s Disease Reveal Neurovascular Defects, Altered Amyloid-&#x3b2; Homeostasis, and Deregulated Expression of Long Noncoding RNAs. J. Alzheimer&#x2019;s Dis. 2015;48:647&#x2013;665. doi: 10.3233/JAD-150398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150398</ArticleId><ArticleId IdType="pmc">PMC4698155</ArticleId><ArticleId IdType="pubmed">26402107</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunckley T., Beach T.G., Ramsey K.E., Grover A., Mastroeni D., Walker D.G., LaFleur B.J., Coon K.D., Brown K.M., Caselli R., et al. Gene expression correlates of neurofibrillary tangles in Alzheimer&#x2019;s disease. Neurobiol. Aging. 2006;27:1359&#x2013;1371. doi: 10.1016/j.neurobiolaging.2005.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2005.08.013</ArticleId><ArticleId IdType="pmc">PMC2259291</ArticleId><ArticleId IdType="pubmed">16242812</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheckel C., Drapeau E., A Frias M., Park C.Y., Fak J., Zucker-Scharff I., Kou Y., Haroutunian V., Ma&#x2019;Ayan A., Buxbaum J., et al. Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain. eLife. 2016;5:e10421. doi: 10.7554/eLife.10421.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.10421</ArticleId><ArticleId IdType="pmc">PMC4798961</ArticleId><ArticleId IdType="pubmed">26894958</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., Feldman H.M., Lu T., Drake D., Lim E.T., Ling K.-H., Bishop N.A., Pan Y., Seo J., Lin Y.-T., et al. REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer&#x2019;s Disease. Cell Rep. 2019;26:1112&#x2013;1127.e9. doi: 10.1016/j.celrep.2019.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.01.023</ArticleId><ArticleId IdType="pmc">PMC6386196</ArticleId><ArticleId IdType="pubmed">30699343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H., Davila-Velderrain J., Peng Z., Gao F., Mohammadi S., Young J.Z., Menon M., He L., Abdurrob F., Jiang X., et al. Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nat. Cell Biol. 2019;570:332&#x2013;337. doi: 10.1038/s41586-019-1195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1195-2</ArticleId><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hondius D.C., Van Nierop P., Li K.W., Hoozemans J.J., Van Der Schors R.C., Van Haastert E.S., Van Der Vies S.M., Rozemuller A.J., Smit A.B. Profiling the human hippocampal proteome at all pathologic stages of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2016;12:654&#x2013;668. doi: 10.1016/j.jalz.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.11.002</ArticleId><ArticleId IdType="pubmed">26772638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno M.S., Lane M., Zhang W., Wolf P., Oliva P., Viel C., Wills A.-M., Alcalay R.N., Scherzer C.R., Shihabuddin L.S., et al. Cerebrospinal fluid proteomics implicates the granin family in Parkinson&#x2019;s disease. Sci. Rep. 2020;10:1&#x2013;11. doi: 10.1038/s41598-020-59414-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-59414-4</ArticleId><ArticleId IdType="pmc">PMC7015906</ArticleId><ArticleId IdType="pubmed">32051502</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., Gonz&#xe1;lez-Morales A., Iloro I., Elortza F., Ferrer I., Gveric D., Fern&#xe1;ndez-Irigoyen J., Santamar&#xed;a E. Unveiling the olfactory proteostatic disarrangement in Parkinson&#x2019;s disease by proteome-wide profiling. Neurobiol. Aging. 2019;73:123&#x2013;134. doi: 10.1016/j.neurobiolaging.2018.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.018</ArticleId><ArticleId IdType="pubmed">30342273</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dijk K.D., Berendse H.W., Drukarch B., Fratantoni S.A., Pham T.V., Piersma S.R., Huisman E., Brev&#xe9; J.J.P., Groenewegen H.J., Jimenez C.R., et al. The Proteome of the Locus Ceruleus in Parkinson&#x2019;s Disease: Relevance to Pathogenesis. Brain Pathol. 2012;22:485&#x2013;498. doi: 10.1111/j.1750-3639.2011.00540.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2011.00540.x</ArticleId><ArticleId IdType="pubmed">21988495</ArticleId></ArticleIdList></Reference><Reference><Citation>Umoh M.E., Dammer E.B., Dai J., Duong D.M., Lah J.J., I Levey A., Gearing M., Glass J.D., Seyfried N.T. A proteomic network approach across the ALS&#x2014;FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. Embo Mol. Med. 2018;10:48&#x2013;62. doi: 10.15252/emmm.201708202.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708202</ArticleId><ArticleId IdType="pmc">PMC5760858</ArticleId><ArticleId IdType="pubmed">29191947</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P., Weydt P., Thal D.R., Weishaupt J.H., Ludolph A.C., Otto M. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Acta Neuropathol. 2019;139:119&#x2013;134. doi: 10.1007/s00401-019-02093-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02093-x</ArticleId><ArticleId IdType="pubmed">31701227</ArticleId></ArticleIdList></Reference><Reference><Citation>Iridoy M.O., Zubiri I., Zelaya M.V., Martinez L., Ausin K., Lach&#xe9;n-Montes M., Santamar&#xed;a E., Fern&#xe1;ndez-Irigoyen J., Pascual I.J. Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Int. J. Mol. Sci. 2018;20:4. doi: 10.3390/ijms20010004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20010004</ArticleId><ArticleId IdType="pmc">PMC6337647</ArticleId><ArticleId IdType="pubmed">30577465</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M.A., An J., Hood B.L., Conrads T.P., Bowser R.P. Label-Free LC&#x2013;MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. J. Proteome Res. 2015;14:4486&#x2013;4501. doi: 10.1021/acs.jproteome.5b00804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.5b00804</ArticleId><ArticleId IdType="pmc">PMC5592736</ArticleId><ArticleId IdType="pubmed">26401960</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese A.M., Sharma A., Mishra P.-S., Vijayalakshmi K., Gowda H., Sathyaprabha T.N., Bharath M.M.S., Nalini A., Alladi P.A., Raju T.R. Chitotriosidase&#x2014;A putative biomarker for sporadic amyotrophic lateral sclerosis. Clin. Proteom. 2013;10:19. doi: 10.1186/1559-0275-10-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1559-0275-10-19</ArticleId><ArticleId IdType="pmc">PMC4220794</ArticleId><ArticleId IdType="pubmed">24295388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T., Chaerkady R., Kammers K., Stewart J.C., Zavala A., Pletnikova O., Troncoso J.C., Rudnicki D.D., Margolis R.L., Cole R.N., et al. Quantitative Proteomic Analysis Reveals Similarities between Huntington&#x2019;s Disease (HD) and Huntington&#x2019;s Disease-Like 2 (HDL2) Human Brains. J. Proteome Res. 2016;15:3266&#x2013;3283. doi: 10.1021/acs.jproteome.6b00448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.6b00448</ArticleId><ArticleId IdType="pmc">PMC5555151</ArticleId><ArticleId IdType="pubmed">27486686</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Q., Strand A., Law W., Faca V.M., FitzGibbon M.P., Hamel N., Houle B., Liu X., May D.H., Poschmann G., et al. Brain-specific Proteins Decline in the Cerebrospinal Fluid of Humans with Huntington Disease. Mol. Cell. Proteom. 2009;8:451&#x2013;466. doi: 10.1074/mcp.M800231-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M800231-MCP200</ArticleId><ArticleId IdType="pmc">PMC2649809</ArticleId><ArticleId IdType="pubmed">18984577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader J.M., Geyer P., M&#xfc;ller J.B., Strauss M.T., Koch M., Leypoldt F., Koertvelyessy P., Bittner D., Schipke C.G., Incesoy E.I., et al. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer&#x2019;s disease. Mol. Syst. Biol. 2020;16:e9356. doi: 10.15252/msb.20199356.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20199356</ArticleId><ArticleId IdType="pmc">PMC7266499</ArticleId><ArticleId IdType="pubmed">32485097</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Ma C., Gearing M., Wang P.G., Chin L.-S., Li L. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 2018;6:1&#x2013;19. doi: 10.1186/s40478-018-0524-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0524-2</ArticleId><ArticleId IdType="pmc">PMC5831854</ArticleId><ArticleId IdType="pubmed">29490708</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyfried N.T., Dammer E.B., Swarup V., Nandakumar D., Duong D.M., Yin L., Deng Q., Nguyen T., Hales C.M., Wingo T., et al. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer&#x2019;s Disease. Cell Syst. 2017;4:60&#x2013;72.e4. doi: 10.1016/j.cels.2016.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2016.11.006</ArticleId><ArticleId IdType="pmc">PMC5269514</ArticleId><ArticleId IdType="pubmed">27989508</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginbotham L., Dammer E.B., Duong D.M., Modeste E., Montine T.J., Lah J.J., Levey A.I., Seyfried N.T. Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer&#x2019;s Disease. Proteomes. 2019;7:30. doi: 10.3390/proteomes7030030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/proteomes7030030</ArticleId><ArticleId IdType="pmc">PMC6789842</ArticleId><ArticleId IdType="pubmed">31461916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo A.P., Fan W., Duong D.M., Gerasimov E.S., Dammer E.B., Liu Y., Harerimana N.V., White B., Thambisetty M., Troncoso J.C., et al. Shared proteomic effects of cerebral atherosclerosis and Alzheimer&#x2019;s disease on the human brain. Nat. Neurosci. 2020;23:696&#x2013;700. doi: 10.1038/s41593-020-0635-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0635-5</ArticleId><ArticleId IdType="pmc">PMC7269838</ArticleId><ArticleId IdType="pubmed">32424284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., Gonz&#xe1;lez-Morales A., Zelaya M.V., P&#xe9;rez-Valderrama E., Aus&#xed;n K., Ferrer I., Fern&#xe1;ndez-Irigoyen J., Santamar&#xed;a E. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer&#x2019;s disease progression. Sci. Rep. 2017;7:1&#x2013;15. doi: 10.1038/s41598-017-09481-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09481-x</ArticleId><ArticleId IdType="pmc">PMC5567385</ArticleId><ArticleId IdType="pubmed">28831118</ArticleId></ArticleIdList></Reference><Reference><Citation>Braschi B., Denny P., Gray K.A., Jones T., Seal R.L., Tweedie S., Yates B., Bruford E. Genenames.org: The HGNC and VGNC resources in 2019. Nucleic Acids Res. 2019;47:D786&#x2013;D792. doi: 10.1093/nar/gky930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky930</ArticleId><ArticleId IdType="pmc">PMC6324057</ArticleId><ArticleId IdType="pubmed">30304474</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusa A. Package &#x201c;venn&#x201d;.  [(accessed on 16 July 2020)];2016  Available online:  https://stat.ethz.ch/pipermail/r-packages/2016/001461.html.</Citation></Reference><Reference><Citation>Kolde R., Package M.K. Package &#x201c;pheatmap&#x201d;.  [(accessed on 2 August 2020)];2015  Available online:  https://mran.microsoft.com/snapshot/2017-09-01/web/packages/pheatmap/pheatmap.pdf.</Citation></Reference><Reference><Citation>Kanehisa M. Novartis Foundation Symposium. The KEGG database. Wiley Online Library.  [(accessed on 24 August 2020)];2002  Available online:  https://onlinelibrary.wiley.com/doi/abs/10.1002/0470857897.ch8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0470857897.ch8</ArticleId></ArticleIdList></Reference><Reference><Citation>The Gene Ontology Consortium Gene ontology consortium: Going forward. Nucleic Acids Res. 2015;43:D1049&#x2013;D1056. doi: 10.1093/nar/gku1179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1179</ArticleId><ArticleId IdType="pmc">PMC4383973</ArticleId><ArticleId IdType="pubmed">25428369</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Wang J., Jaehnig E.J., Shi Z., Zhang B. WebGestalt 2019: Gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47:W199&#x2013;W205. doi: 10.1093/nar/gkz401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz401</ArticleId><ArticleId IdType="pmc">PMC6602449</ArticleId><ArticleId IdType="pubmed">31114916</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenhofer U., Kothmeier A., Hochreiter S. APCluster: An R package for affinity propagation clustering. Bioinform. 2011;27:2463&#x2013;2464. doi: 10.1093/bioinformatics/btr406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr406</ArticleId><ArticleId IdType="pubmed">21737437</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey B.J., Dueck D. Clustering by Passing Messages between Data Points. Science. 2007;315:972&#x2013;976. doi: 10.1126/science.1136800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1136800</ArticleId><ArticleId IdType="pubmed">17218491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S., May M.J., Kopp E.B. NF-&#x3ba;B and rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998;16:225&#x2013;260. doi: 10.1146/annurev.immunol.16.1.225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.16.1.225</ArticleId><ArticleId IdType="pubmed">9597130</ArticleId></ArticleIdList></Reference><Reference><Citation>Luque I., G&#xe9;linas C. Rel/NF-&#x3ba;B and I&#x3ba;B factors in oncogenesis. Semin. Cancer Biol. 1997;8:103&#x2013;111. doi: 10.1006/scbi.1997.0061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/scbi.1997.0061</ArticleId><ArticleId IdType="pubmed">9299588</ArticleId></ArticleIdList></Reference><Reference><Citation>Grilli M., Memo M. Nuclear factor-&#x3ba;B/Rel proteins. Biochem. Pharmacol. 1999;57:1&#x2013;7. doi: 10.1016/S0006-2952(98)00214-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-2952(98)00214-7</ArticleId><ArticleId IdType="pubmed">9920279</ArticleId></ArticleIdList></Reference><Reference><Citation>Foxwell B., Browne K., Bondeson J., Clarke C., De Martin R., Brennan F., Feldmann M. Efficient adenoviral infection with I B reveals that macrophage tumor necrosis factor production in rheumatoid arthritis is NF- B dependent. Proc. Natl. Acad. Sci. USA. 1998;95:8211&#x2013;8215. doi: 10.1073/pnas.95.14.8211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.14.8211</ArticleId><ArticleId IdType="pmc">PMC20955</ArticleId><ArticleId IdType="pubmed">9653166</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordby Y., Richardsen E., Rakaee M., Ness N., Donnem T., Patel H.R.H., Busund L.-T., Bremnes R.M., Andersen S. High expression of PDGFR-&#x3b2; in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Sci. Rep. 2017;7:43378. doi: 10.1038/srep43378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43378</ArticleId><ArticleId IdType="pmc">PMC5324133</ArticleId><ArticleId IdType="pubmed">28233816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ib&#xe1;&#xf1;ez K., Boullosa C., Tabar&#xe9;s-Seisdedos R., Baudot A., Valencia A. Molecular Evidence for the Inverse Comorbidity between Central Nervous System Disorders and Cancers Detected by Transcriptomic Meta-analyses. Plos Genet. 2014;10:e1004173. doi: 10.1371/journal.pgen.1004173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004173</ArticleId><ArticleId IdType="pmc">PMC3930576</ArticleId><ArticleId IdType="pubmed">24586201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayraktar A., Onal-Suzek T., Suzek B.E., Baysal O. Meta-analysis of Gene Expression in Neurodegenerative Diseases Reveals Patterns in GABA Synthesis and Heat Stress Pathways. arXiv. 20191909.07469</Citation></Reference><Reference><Citation>Kampinga H.H., Bergink S. Heat shock proteins as potential targets for protective strategies in neurodegeneration. Lancet Neurol. 2016;15:748&#x2013;759. doi: 10.1016/S1474-4422(16)00099-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)00099-5</ArticleId><ArticleId IdType="pubmed">27106072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltenbach L.S., Romero E., Becklin R.R., Chettier R., Bell R., Phansalkar A., Strand A., Torcassi C., Savage J., Hurlburt A., et al. Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration. Plos Genet. 2007;3:e82. doi: 10.1371/journal.pgen.0030082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0030082</ArticleId><ArticleId IdType="pmc">PMC1866352</ArticleId><ArticleId IdType="pubmed">17500595</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K., Barmada S.J. TDP43 and RNA instability in amyotrophic lateral sclerosis. Brain Res. 2018;1693:67&#x2013;74. doi: 10.1016/j.brainres.2018.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.01.015</ArticleId><ArticleId IdType="pmc">PMC5997512</ArticleId><ArticleId IdType="pubmed">29395044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J., Yeo G.W. Genetic mutations in RNA-binding proteins and their roles in ALS. Qual. Life Res. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Huntley M.L., Perry G., Wang X. Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem. 2018;146:7&#x2013;20. doi: 10.1111/jnc.14327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai B.S., Schneider J.A., Li J.-L., Carvey P.M., Hendey B. Evidence of angiogenic vessels in Alzheimer&#x2019;s disease. J. Neural Transm. 2009;116:587&#x2013;597. doi: 10.1007/s00702-009-0226-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-009-0226-9</ArticleId><ArticleId IdType="pmc">PMC2753398</ArticleId><ArticleId IdType="pubmed">19370387</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit W.J., Mrak R.E., Griffin W.S.T. Microglia and neuroinflammation: A pathological perspective. J. Neuroinflamm. 2004;1:14. doi: 10.1186/1742-2094-1-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-1-14</ArticleId><ArticleId IdType="pmc">PMC509427</ArticleId><ArticleId IdType="pubmed">15285801</ArticleId></ArticleIdList></Reference><Reference><Citation>Naldini A. Role of Inflammatory Mediators in Angiogenesis. Curr. Drug Target -Inflamm. Allergy. 2005;4:3&#x2013;8. doi: 10.2174/1568010053622830.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568010053622830</ArticleId><ArticleId IdType="pubmed">15720228</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammas P., Sanchez A., Tripathy D., Luo E., Martinez J. Vascular signaling abnormalities in Alzheimer disease. Clevel. Clin. J. Med. 2011;78:S50&#x2013;S53. doi: 10.3949/ccjm.78.s1.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.78.s1.09</ArticleId><ArticleId IdType="pubmed">21972332</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallon M., Chang J., Zhang H., Kuo C.J. Developmental and pathological angiogenesis in the central nervous system. Cell. Mol. Life Sci. 2014;71:3489&#x2013;3506. doi: 10.1007/s00018-014-1625-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1625-0</ArticleId><ArticleId IdType="pmc">PMC4165859</ArticleId><ArticleId IdType="pubmed">24760128</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C., Blechert B., Gaertner F.C., Drecoll E., Mueller J., Weber G.F., Drzezga A., Essler M. In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer&#x2019;s disease. Angiogenesis. 2006;9:59&#x2013;65. doi: 10.1007/s10456-006-9030-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-006-9030-4</ArticleId><ArticleId IdType="pubmed">16821113</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagi S.S., Himadri P., Ruma D., Sharma S., Pauline T. Mrinalini Selenium protects the hypoxia induced apoptosis in neuroblastoma cells through upregulation of Bcl-2. Brain Res. 2008;1209:29&#x2013;39. doi: 10.1016/j.brainres.2008.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2008.02.041</ArticleId><ArticleId IdType="pubmed">18405886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia D., Ardekani M.S., Shi Q., Movafagh S. Hypoxia and Human Diseases. IntechOpen; London, UK: 2017. Hypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases.</Citation></Reference><Reference><Citation>Song I., Dityatev A. Crosstalk between glia, extracellular matrix and neurons. Brain Res. Bull. 2018;136:101&#x2013;108. doi: 10.1016/j.brainresbull.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2017.03.003</ArticleId><ArticleId IdType="pubmed">28284900</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K., Han K., Tilve S., Wu K., Geller H.M., Sack M.N. Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation. Glia. 2018;66:2427&#x2013;2437. doi: 10.1002/glia.23482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23482</ArticleId><ArticleId IdType="pmc">PMC6275110</ArticleId><ArticleId IdType="pubmed">30378174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtishi A., Rosen B., Patil K.S., Alves G.W., M&#xf8;ller S.G. Cellular Proteostasis in Neurodegeneration. Mol. Neurobiol. 2019;56:3676&#x2013;3689. doi: 10.1007/s12035-018-1334-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1334-z</ArticleId><ArticleId IdType="pubmed">30182337</ArticleId></ArticleIdList></Reference><Reference><Citation>Iurlaro R., Mu&#xf1;oz-Pinedo C. Cell death induced by endoplasmic reticulum stress. Febs J. 2016;283:2640&#x2013;2652. doi: 10.1111/febs.13598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13598</ArticleId><ArticleId IdType="pubmed">26587781</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores B.N., Li X., Malik A.M., Martinez J., Beg A.A., Barmada S.J. An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration. Cell Rep. 2019;27:1133&#x2013;1150.e8. doi: 10.1016/j.celrep.2019.03.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.093</ArticleId><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatino J.J., Jr., Pr&#xf6;bstel A.-K., Zamvil S. B cells in autoimmune and neurodegenerative central nervous system diseases. Nat. Rev. Neurosci. 2019;20:728&#x2013;745. doi: 10.1038/s41583-019-0233-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0233-2</ArticleId><ArticleId IdType="pubmed">31712781</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt B., Vajkoczy P., Weller R.O. The movers and shapers in immune privilege of the CNS. Nat. Immunol. 2017;18:123&#x2013;131. doi: 10.1038/ni.3666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3666</ArticleId><ArticleId IdType="pubmed">28092374</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A., Plog B.A., Antila S., Alitalo K., Smith N.A., Kipnis J. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J. Clin. Investig. 2017;127:3210&#x2013;3219. doi: 10.1172/JCI90603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90603</ArticleId><ArticleId IdType="pmc">PMC5669566</ArticleId><ArticleId IdType="pubmed">28862640</ArticleId></ArticleIdList></Reference><Reference><Citation>Anthony I.C., Crawford D.H., Bell J.E. B lymphocytes in the normal brain: Contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain. 2003;126:1058&#x2013;1067. doi: 10.1093/brain/awg118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awg118</ArticleId><ArticleId IdType="pubmed">12690046</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado-Santos J., Saji E., Tr&#xf6;scher A.R., Paunovic M., Liblau R., Gabriely G., Bien C.G., Bauer J., Lassmann H. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain. 2018;141:2066&#x2013;2082. doi: 10.1093/brain/awy151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy151</ArticleId><ArticleId IdType="pmc">PMC6022681</ArticleId><ArticleId IdType="pubmed">29873694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowarik M.C., Grummel V., Wemlinger S., Buck D., Weber M.S., Berthele A., Hemmer B. Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases. J. Neurol. 2014;261:130&#x2013;143. doi: 10.1007/s00415-013-7145-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7145-2</ArticleId><ArticleId IdType="pubmed">24162037</ArticleId></ArticleIdList></Reference><Reference><Citation>Brochard V., Combadi&#xe8;re B., Prigent A., Laouar Y., Perrin A., Beray-Berthat V., Bonduelle O., Alvarez-Fischer D., Callebert J., Launay J.-M., et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Investig. 2008;119:182&#x2013;192. doi: 10.1172/JCI36470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI36470</ArticleId><ArticleId IdType="pmc">PMC2613467</ArticleId><ArticleId IdType="pubmed">19104149</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr C.F., Rowe D.B., Mizuno Y., Mori H., Halliday G.M. A possible role for humoral immunity in the pathogenesis of Parkinson&#x2019;s disease. Brain. 2005;128:2665&#x2013;2674. doi: 10.1093/brain/awh625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh625</ArticleId><ArticleId IdType="pubmed">16219675</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Ortiz M.E., Chen-Plotkin A.S. Omics in Neurodegenerative Disease: Hope or Hype? Trends Genet. 2020;36:152&#x2013;159. doi: 10.1016/j.tig.2019.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2019.12.002</ArticleId><ArticleId IdType="pmc">PMC7065657</ArticleId><ArticleId IdType="pubmed">31932096</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jager P.L., Yang H.-S., Bennett D.A. Deconstructing and targeting the genomic architecture of human neurodegeneration. Nat. Neurosci. 2018;21:1310&#x2013;1317. doi: 10.1038/s41593-018-0240-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0240-z</ArticleId><ArticleId IdType="pubmed">30258235</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker K., Bluhm A., Casas-Vila N., Dinges N., DeJung M., Sayols S., Kreutz C., Roignant J.-Y., Butter F., Legewie S. Quantifying post-transcriptional regulation in the development of Drosophila melanogaster. Nat. Commun. 2018;9:1&#x2013;14. doi: 10.1038/s41467-018-07455-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07455-9</ArticleId><ArticleId IdType="pmc">PMC6255845</ArticleId><ArticleId IdType="pubmed">30478415</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoni C., Lewis P.A., Ferrari R. Network Analysis for Complex Neurodegenerative Diseases. Curr. Genet. Med. Rep. 2020;8:17&#x2013;25. doi: 10.1007/s40142-020-00181-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40142-020-00181-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Lai S., Chen H., Chen M. Protein&#x2013;protein interaction network with machine learning models and multiomics data reveal potential neurodegenerative disease-related proteins. Hum. Mol. Genet. 2020;29:1378&#x2013;1387. doi: 10.1093/hmg/ddaa065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa065</ArticleId><ArticleId IdType="pubmed">32277755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.D., Wang D. Multiview learning for understanding functional multiomics. Plos Comput. Biol. 2020;16:e1007677. doi: 10.1371/journal.pcbi.1007677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1007677</ArticleId><ArticleId IdType="pmc">PMC7117667</ArticleId><ArticleId IdType="pubmed">32240163</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>